<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Acute lymphoblastic leukemia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Acute_lymphoblastic_leukemia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Acute_lymphoblastic_leukemia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Acute_lymphoblastic_leukemia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Acute_lymphoblastic_leukemia","wgTitle":"Acute lymphoblastic leukemia","wgCurRevisionId":668901393,"wgRevisionId":668901393,"wgArticleId":837167,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","All articles with failed verification","Articles with failed verification from February 2013","All articles with unsourced statements","Articles with unsourced statements from April 2014","Articles with unsourced statements from September 2012","Articles to be merged from January 2015","All articles to be merged","Articles with DMOZ links","Articles that use a Medicine navs subtemplate","Acute lymphocytic leukemia","Pediatrics"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Acute_lymphoblastic_leukemia","wgRelevantArticleId":837167,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Acute_lymphocytic_leukemia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Acute_leukemia-ALL.jpg/88px-Acute_leukemia-ALL.jpg","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Acute_lymphoblastic_leukemia","wgWikibaseItemId":"Q180664"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Acute_lymphoblastic_leukemia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Acute lymphoblastic leukemia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Acute_lymphocytic_leukemia&amp;redirect=no" title="Acute lymphocytic leukemia">Acute lymphocytic leukemia</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Acute lymphoblastic leukemia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Acute_leukemia-ALL.jpg" class="image"><img alt="Acute leukemia-ALL.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Acute_leukemia-ALL.jpg/230px-Acute_leukemia-ALL.jpg" width="230" height="262" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Acute_leukemia-ALL.jpg/345px-Acute_leukemia-ALL.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/0/0e/Acute_leukemia-ALL.jpg 2x" data-file-width="347" data-file-height="395" /></a></td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Hematology" title="Hematology">Hematology</a> and <a href="/wiki/Oncology" title="Oncology">oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C91.0">C91.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=204.0">204.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I98353/">9835/3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb195.htm">195</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic3146.htm">med/3146</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic2587.htm#">ped/2587</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D054198">D054198</a></td>
</tr>
</table>
<p><b>Acute lymphoblastic leukemia</b>, also known as <b>acute lymphocytic leukemia</b> or <b>acute lymphoid leukemia</b> (<b>ALL</b>), is an <a href="/wiki/Acute_(medicine)" title="Acute (medicine)">acute</a> form of <a href="/wiki/Leukemia" title="Leukemia">leukemia</a>, or <a href="/wiki/Hematological_malignancy" title="Hematological malignancy" class="mw-redirect">cancer of the white blood cells</a>, characterized by the overproduction and accumulation of <a href="/wiki/Malignant" title="Malignant" class="mw-redirect">cancerous</a>, immature <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a>—known as <a href="/wiki/Lymphoblast" title="Lymphoblast">lymphoblasts</a>.<sup id="cite_ref-PMSR_1-0" class="reference"><a href="#cite_note-PMSR-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-AMSR_2-0" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup> In persons with ALL, lymphoblasts are overproduced in the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> and continuously multiply, causing damage and death by inhibiting the production of normal cells—such as <a href="/wiki/Red_blood_cell" title="Red blood cell">red</a> and <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a> and <a href="/wiki/Platelets" title="Platelets" class="mw-redirect">platelets</a>—in the bone marrow and by spreading (<a href="/wiki/Infiltration_(medical)" title="Infiltration (medical)">infiltrating</a>) to other organs. ALL is most common in childhood with a peak incidence at 2–5 years of age, and another peak in old age.<sup id="cite_ref-AMSR_2-1" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<p>The symptoms of ALL are indicative of a reduced production of functional blood cells, because the <a href="/wiki/Leukemia" title="Leukemia">leukemia</a> wastes the resources of the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a>, which are normally used to produce new, functioning blood cells.<sup id="cite_ref-PMSR_1-1" class="reference"><a href="#cite_note-PMSR-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-AMSR_2-2" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup> These symptoms can include fever, increased risk of infection (especially bacterial infections like <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>, due to <a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a>; symptoms of such an infection include <a href="/wiki/Dyspnea" title="Dyspnea">shortness of breath</a>, chest pain, cough, vomiting, changes in bowel or bladder habits), increased tendency to bleed (due to <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a>) and signs indicative of <a href="/wiki/Anemia" title="Anemia">anemia</a> including <a href="/wiki/Pallor" title="Pallor">pallor</a>, <a href="/wiki/Tachycardia" title="Tachycardia">tachycardia</a> (high heart rate), fatigue and headache.<sup id="cite_ref-PMSR_1-2" class="reference"><a href="#cite_note-PMSR-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-AMSR_2-3" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<p>About 6,000 cases are reported in the <a href="/wiki/United_States" title="United States">US</a> every year;<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> statistics from other countries are difficult to come by, although it is known to be more common in the <a href="/wiki/United_States" title="United States">United States</a>, <a href="/wiki/Italy" title="Italy">Italy</a> and <a href="/wiki/Costa_Rica" title="Costa Rica">Costa Rica</a>.<sup id="cite_ref-AMSR_2-4" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup> Cure is a realistic goal and is achieved in over 80% of affected children, although only 20-40% of adults can be cured.<sup id="cite_ref-PMSR_1-3" class="reference"><a href="#cite_note-PMSR-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-AMSR_2-5" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup> "Acute" refers to the relatively short time course of the disease to differentiate it from <a href="/wiki/Chronic_lymphocytic_leukemia" title="Chronic lymphocytic leukemia" class="mw-redirect">chronic lymphocytic leukemia</a>, which has a potential time course of many years.<sup id="cite_ref-MM_4-0" class="reference"><a href="#cite_note-MM-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Harrison_5-0" class="reference"><a href="#cite_note-Harrison-5"><span>[</span>5<span>]</span></a></sup></p>
<p>It was one of the first cancers for which an effective chemotherapeutic treatment was developed as <a href="/wiki/Antifolates" title="Antifolates" class="mw-redirect">antifolates</a> like <a href="/wiki/Aminopterin" title="Aminopterin">aminopterin</a> and <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> were developed in the late 1940s by <a href="/wiki/Sidney_Farber" title="Sidney Farber">Sidney Farber</a> and <a href="/wiki/Yellapragada_Subbarow" title="Yellapragada Subbarow">Yellapragada Subbarow</a>.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-malady_7-0" class="reference"><a href="#cite_note-malady-7"><span>[</span>7<span>]</span></a></sup> At this point in time a doctor did not need a patient's or parent's consent to try an experimental treatment on them (as the <a href="/wiki/Nuremberg_code" title="Nuremberg code" class="mw-redirect">Nuremberg code</a> had not been signed at the time) and he initially tried <a href="/wiki/Folic_acid" title="Folic acid">folic acid</a> supplementation as a treatment for ALL, which had disastrous consequences — he inadvertently accelerated the deaths of these children.<sup id="cite_ref-malady_7-1" class="reference"><a href="#cite_note-malady-7"><span>[</span>7<span>]</span></a></sup></p>
<div class="toclimit-3">
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Pathophysiology"><span class="tocnumber">2</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-4"><a href="#Cytogenetics"><span class="tocnumber">3.1</span> <span class="toctext">Cytogenetics</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Classification"><span class="tocnumber">3.2</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-3 tocsection-6"><a href="#FAB"><span class="tocnumber">3.2.1</span> <span class="toctext">FAB</span></a></li>
<li class="toclevel-3 tocsection-7"><a href="#World_Health_Organization"><span class="tocnumber">3.2.2</span> <span class="toctext">World Health Organization</span></a></li>
<li class="toclevel-3 tocsection-8"><a href="#Variant_features"><span class="tocnumber">3.2.3</span> <span class="toctext">Variant features</span></a></li>
<li class="toclevel-3 tocsection-9"><a href="#Immunophenotyping"><span class="tocnumber">3.2.4</span> <span class="toctext">Immunophenotyping</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-10"><a href="#Treatment"><span class="tocnumber">4</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#Chemotherapy"><span class="tocnumber">4.1</span> <span class="toctext">Chemotherapy</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Radiation_therapy"><span class="tocnumber">4.2</span> <span class="toctext">Radiation therapy</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Biological_therapy"><span class="tocnumber">4.3</span> <span class="toctext">Biological therapy</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Immunotherapy"><span class="tocnumber">4.4</span> <span class="toctext">Immunotherapy</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-15"><a href="#Prognosis"><span class="tocnumber">5</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a>
<ul>
<li class="toclevel-2 tocsection-17"><a href="#United_States"><span class="tocnumber">6.1</span> <span class="toctext">United States</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#United_Kingdom"><span class="tocnumber">6.2</span> <span class="toctext">United Kingdom</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#Pregnancy"><span class="tocnumber">7</span> <span class="toctext">Pregnancy</span></a></li>
<li class="toclevel-1 tocsection-20"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Initial <a href="/wiki/Symptoms" title="Symptoms" class="mw-redirect">symptoms</a> are not specific to ALL, but worsen to the point that medical help is sought. They result from the lack of normal and healthy blood cells because they are crowded out by malignant and immature leukocytes (white blood cells). Therefore, people with ALL experience symptoms from malfunctioning of their erythrocytes (red blood cells), leukocytes, and platelets. Laboratory tests that might show abnormalities include blood count tests, renal function tests, electrolyte tests, and liver enzyme tests.<sup id="cite_ref-AMSR_2-6" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<p>The signs and symptoms of ALL are variable but follow from bone marrow replacement and/or organ infiltration.<sup id="cite_ref-AMSR_2-7" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<ul>
<li>Generalized weakness and fatigue</li>
<li>Anemia</li>
<li>Dizziness</li>
<li>Frequent or unexplained <a href="/wiki/Fever" title="Fever">fever</a> and <a href="/wiki/Infection" title="Infection">infection</a></li>
<li>Weight loss and/or loss of appetite</li>
<li>Excessive and unexplained bruising</li>
<li>Bone pain, joint pain (caused by the spread of "blast" cells to the surface of the bone or into the joint from the marrow cavity)</li>
<li>Breathlessness</li>
<li>Enlarged lymph nodes, liver and/or spleen</li>
<li>Pitting edema (swelling) in the lower limbs and/or abdomen</li>
<li>Petechiae, which are tiny red spots or lines in the skin due to low <a href="/wiki/Platelet" title="Platelet">platelet</a> levels</li>
</ul>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=2" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg/220px-Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg.png" width="220" height="324" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg/330px-Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/18/Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg/440px-Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg.png 2x" data-file-width="243" data-file-height="358" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diagram_showing_the_cell_that_ALL_starts_in_CRUK_295.svg" class="internal" title="Enlarge"></a></div>
Diagram showing the cell ALL starts in</div>
</div>
</div>
<p>In general, cancer is caused by damage to <a href="/wiki/Deoxyribonucleic_Acid" title="Deoxyribonucleic Acid" class="mw-redirect">DNA</a> that leads to uncontrolled cellular growth and spreads throughout the body, either by increasing chemical signals that cause growth or by interrupting chemical signals that control growth. Damage can be caused through the formation of <a href="/wiki/Fusion_genes" title="Fusion genes" class="mw-redirect">fusion genes</a>, as well as the dysregulation of a <a href="/wiki/Proto-oncogene" title="Proto-oncogene" class="mw-redirect">proto-oncogene</a> via juxtaposition of it to the promoter of another gene, e.g. the <a href="/wiki/T-cell_receptor" title="T-cell receptor" class="mw-redirect">T-cell receptor</a> gene. This damage may be caused by environmental factors such as chemicals, drugs or radiation, and occurs naturally during <a href="/wiki/Mitosis" title="Mitosis">mitosis</a> or other normal processes (although cells have numerous mechanisms of <a href="/wiki/DNA_repair" title="DNA repair">DNA repair</a> that help to reduce this).</p>
<p>ALL is associated with exposure to <a href="/wiki/Ionizing_radiation" title="Ionizing radiation">radiation</a> and chemicals in animals and humans. High level radiation exposure is a known risk factor for developing leukemia, as found by studies of survivors of <a href="/wiki/Atom_bomb" title="Atom bomb" class="mw-redirect">atom bomb</a> exposure in <a href="/wiki/Hiroshima" title="Hiroshima">Hiroshima</a> and <a href="/wiki/Nagasaki,_Nagasaki" title="Nagasaki, Nagasaki" class="mw-redirect">Nagasaki</a>.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability"><span title="The material near this tag failed verification of its source citation(s). (February 2013)">not in citation given</span></a></i>]</sup> In animals, exposure to <a href="/wiki/Benzene" title="Benzene">benzene</a> and other chemicals can cause leukemia.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2014)">citation needed</span></a></i>]</sup> Epidemiological studies have associated leukemia with workplace exposure to chemicals, but these studies are not as conclusive. Some evidence suggests that secondary leukemia can develop in individuals treated for other cancers with radiation and chemotherapy as a result of that treatment.<sup id="cite_ref-smith_9-0" class="reference"><a href="#cite_note-smith-9"><span>[</span>9<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=3" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnosing</a> ALL begins with a medical history, <a href="/wiki/Physical_examination" title="Physical examination">physical examination</a>, <a href="/wiki/Full_blood_count" title="Full blood count" class="mw-redirect">complete blood count</a>, and blood smears. Because the symptoms are so general, many other diseases with similar symptoms must be excluded. Typically, the higher the white blood cell count the worse the prognosis.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> Blast cells are seen on <a href="/wiki/Blood_smear" title="Blood smear" class="mw-redirect">blood smear</a> in the majority of cases (blast cells are precursors (stem cells) to all immune cell lines). A <a href="/wiki/Bone_marrow_biopsy" title="Bone marrow biopsy" class="mw-redirect">bone marrow biopsy</a> is conclusive proof of ALL.<sup id="cite_ref-Harrison_5-1" class="reference"><a href="#cite_note-Harrison-5"><span>[</span>5<span>]</span></a></sup> A <a href="/wiki/Lumbar_puncture" title="Lumbar puncture">lumbar puncture</a> (also known as a spinal tap) will indicate if the spinal column and <a href="/wiki/Central_nervous_system" title="Central nervous system">brain</a> have been invaded.</p>
<p><a href="/wiki/Histopathology" title="Histopathology">Pathological</a> examination, <a href="/wiki/Cytogenetics" title="Cytogenetics">cytogenetics</a> (in particular the presence of <a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a>), and <a href="/wiki/Immunophenotyping" title="Immunophenotyping">immunophenotyping</a> establish whether myeloblastic (neutrophils, eosinophils, or basophils) or lymphoblastic (<a href="/wiki/B_lymphocyte" title="B lymphocyte" class="mw-redirect">B lymphocytes</a> or <a href="/wiki/T_lymphocyte" title="T lymphocyte" class="mw-redirect">T lymphocytes</a>) cells are the problem. RNA testing can establish how aggressive the disease is; different mutations have been associated with shorter or longer survival. <a href="/wiki/Immunohistochemistry" title="Immunohistochemistry">Immunohistochemicaltesting</a> may reveal <a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT</a> or <a href="/wiki/Neprilysin" title="Neprilysin">CALLA</a> antigens on the surface of leukemic cells. TdT is a protein expressed early in the development of pre-T and pre-B cells, whereas <a href="/wiki/Neprilysin" title="Neprilysin">CALLA</a> is an antigen found in 80% of ALL cases and also in the "blast crisis" of <a href="/wiki/Chronic_myelogenous_leukemia" title="Chronic myelogenous leukemia">CML</a>.</p>
<p><a href="/wiki/Medical_imaging" title="Medical imaging">Medical imaging</a> (such as <a href="/wiki/Medical_ultrasonography" title="Medical ultrasonography" class="mw-redirect">ultrasound</a> or <a href="/wiki/CT_scan" title="CT scan">CT scanning</a>) can find invasion of other <a href="/wiki/Organ_(anatomy)" title="Organ (anatomy)">organs</a> commonly the <a href="/wiki/Lung" title="Lung">lung</a>, liver, spleen, lymph nodes, brain, kidneys, and reproductive organs.<sup id="cite_ref-MM_4-1" class="reference"><a href="#cite_note-MM-4"><span>[</span>4<span>]</span></a></sup></p>
<ul class="gallery mw-gallery-traditional">
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:29.5px auto;"><a href="/wiki/File:ALL_-_Peripherial_Blood_-_Diagnosis_-_01.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/ALL_-_Peripherial_Blood_-_Diagnosis_-_01.jpg/120px-ALL_-_Peripherial_Blood_-_Diagnosis_-_01.jpg" width="120" height="91" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/ALL_-_Peripherial_Blood_-_Diagnosis_-_01.jpg/180px-ALL_-_Peripherial_Blood_-_Diagnosis_-_01.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1f/ALL_-_Peripherial_Blood_-_Diagnosis_-_01.jpg/240px-ALL_-_Peripherial_Blood_-_Diagnosis_-_01.jpg 2x" data-file-width="760" data-file-height="574" /></a></div>
</div>
<div class="gallerytext">
<p>acute lymphoblastic leukemia (ALL), peripheral blood of a child, Pappenheim stain, magnification x100</p>
</div>
</div>
</li>
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:30px auto;"><a href="/wiki/File:ALL-KM-2.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a1/ALL-KM-2.jpg/120px-ALL-KM-2.jpg" width="120" height="90" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a1/ALL-KM-2.jpg/180px-ALL-KM-2.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a1/ALL-KM-2.jpg/240px-ALL-KM-2.jpg 2x" data-file-width="567" data-file-height="425" /></a></div>
</div>
<div class="gallerytext">
<p>bone marrow smear (large magnification) from a patient with acute lymphoblastic leukemia</p>
</div>
</div>
</li>
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:30px auto;"><a href="/wiki/File:ALL-KM-3.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/ALL-KM-3.jpg/120px-ALL-KM-3.jpg" width="120" height="90" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/ALL-KM-3.jpg/180px-ALL-KM-3.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a4/ALL-KM-3.jpg/240px-ALL-KM-3.jpg 2x" data-file-width="713" data-file-height="536" /></a></div>
</div>
<div class="gallerytext">
<p>bone marrow smear from a patient with acute lymphoblastic leukemia</p>
</div>
</div>
</li>
</ul>
<h3><span class="mw-headline" id="Cytogenetics">Cytogenetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=4" title="Edit section: Cytogenetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Cytogenetic <a href="/wiki/Translocations" title="Translocations" class="mw-redirect">translocations</a> associated with specific molecular genetic abnormalities in ALL</p>
<table class="wikitable">
<tr>
<th>Cytogenetic translocation</th>
<th>Molecular genetic abnormality</th>
<th>%</th>
</tr>
<tr>
<td>cryptic t(12;21)</td>
<td><a href="/wiki/ETV6" title="ETV6">TEL</a>-<a href="/wiki/RUNX1" title="RUNX1">AML1</a> fusion<sup id="cite_ref-pmid15837750_11-0" class="reference"><a href="#cite_note-pmid15837750-11"><span>[</span>11<span>]</span></a></sup></td>
<td>25.4%<sup id="cite_ref-pmid18665825_12-0" class="reference"><a href="#cite_note-pmid18665825-12"><span>[</span>12<span>]</span></a></sup></td>
</tr>
<tr>
<td>t(1;19)(q23;p13)</td>
<td><a href="/wiki/E2A" title="E2A" class="mw-redirect">E2A</a>-<a href="/wiki/Pre-B-cell_leukemia_homeobox" title="Pre-B-cell leukemia homeobox">PBX</a> (<a href="/wiki/PBX1" title="PBX1">PBX1</a>) fusion<sup id="cite_ref-pmid10500199_13-0" class="reference"><a href="#cite_note-pmid10500199-13"><span>[</span>13<span>]</span></a></sup></td>
<td>4.8%<sup id="cite_ref-pmid18665825_12-1" class="reference"><a href="#cite_note-pmid18665825-12"><span>[</span>12<span>]</span></a></sup></td>
</tr>
<tr>
<td>t(9;22)(q34;q11)</td>
<td><a href="/wiki/BCR-ABL" title="BCR-ABL" class="mw-redirect">BCR-ABL</a> fusion(P185)<sup id="cite_ref-pmid16080957_14-0" class="reference"><a href="#cite_note-pmid16080957-14"><span>[</span>14<span>]</span></a></sup></td>
<td>1.6%<sup id="cite_ref-pmid18665825_12-2" class="reference"><a href="#cite_note-pmid18665825-12"><span>[</span>12<span>]</span></a></sup></td>
</tr>
<tr>
<td>t(4;11)(q21;q23)</td>
<td><a href="/wiki/MLL_(gene)" title="MLL (gene)" class="mw-redirect">MLL</a>-<a href="/wiki/AF4/FMR2_family_member_1" title="AF4/FMR2 family member 1" class="mw-redirect">AF4</a> fusion<sup id="cite_ref-pmid14990976_15-0" class="reference"><a href="#cite_note-pmid14990976-15"><span>[</span>15<span>]</span></a></sup></td>
<td>1.6%<sup id="cite_ref-pmid18665825_12-3" class="reference"><a href="#cite_note-pmid18665825-12"><span>[</span>12<span>]</span></a></sup></td>
</tr>
<tr>
<td>t(8;14)(q24;q32)</td>
<td><a href="/wiki/Immunoglobulin_heavy_chain" title="Immunoglobulin heavy chain">IGH</a>-<a href="/wiki/MYC" title="MYC" class="mw-redirect">MYC</a> fusion<sup id="cite_ref-pmid15852472_16-0" class="reference"><a href="#cite_note-pmid15852472-16"><span>[</span>16<span>]</span></a></sup></td>
<td></td>
</tr>
<tr>
<td>t(11;14)(p13;q11)</td>
<td><a href="/wiki/T-cell_receptor" title="T-cell receptor" class="mw-redirect">TCR</a>-<a href="/wiki/RBTN2" title="RBTN2" class="mw-redirect">RBTN2</a> fusion<sup id="cite_ref-pmid7497440_17-0" class="reference"><a href="#cite_note-pmid7497440-17"><span>[</span>17<span>]</span></a></sup></td>
<td></td>
</tr>
</table>
<p>12;21 is the most common translocation and portends a good prognosis. 4;11 is the most common in children under 12 months and portends a poor prognosis.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (September 2012)">citation needed</span></a></i>]</sup></p>
<h3><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=5" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>As ALL is not a solid tumour, the <a href="/wiki/TNM_staging_system" title="TNM staging system">TNM</a> notation as used in solid cancers is of little use.</p>
<h4><span class="mw-headline" id="FAB">FAB</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=6" title="Edit section: FAB">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Subtyping of the various forms of ALL used to be done according to the <a href="/wiki/French-American-British_classification" title="French-American-British classification" class="mw-redirect">French-American-British (FAB) classification</a>,<sup id="cite_ref-urlACS_::_How_Is_Acute_Lymphocytic_Leukemia_Classified.3F_18-0" class="reference"><a href="#cite_note-urlACS_::_How_Is_Acute_Lymphocytic_Leukemia_Classified.3F-18"><span>[</span>18<span>]</span></a></sup> which was used for all acute leukemias (including <a href="/wiki/Acute_myelogenous_leukemia" title="Acute myelogenous leukemia" class="mw-redirect">acute myelogenous leukemia</a>, AML).</p>
<ul>
<li>ALL-L1: small uniform cells</li>
<li>ALL-L2: large varied cells</li>
<li>ALL-L3: large varied cells with <a href="/wiki/Vacuole" title="Vacuole">vacuoles</a> (bubble-like features)</li>
</ul>
<p>Each subtype is then further classified by determining the surface markers of the abnormal lymphocytes, called immunophenotyping. There are 2 main immunologic types: pre-B cell and pre-T cell. The mature B-cell ALL (L3) is now classified as <a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's lymphoma</a>/leukemia. Subtyping helps determine the prognosis and most appropriate treatment in treating ALL.</p>
<h4><span class="mw-headline" id="World_Health_Organization">World Health Organization</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=7" title="Edit section: World Health Organization">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<table class="metadata plainlinks ambox ambox-move" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Mergefrom.svg/50px-Mergefrom.svg.png" width="50" height="20" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Mergefrom.svg/75px-Mergefrom.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Mergefrom.svg/100px-Mergefrom.svg.png 2x" data-file-width="50" data-file-height="20" /></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">It has been suggested that <i><a href="/wiki/Lymphoblastic_lymphoma" title="Lymphoblastic lymphoma">lymphoblastic lymphoma</a></i> be <a href="/wiki/Wikipedia:Merging" title="Wikipedia:Merging">merged</a> into this article. (<a href="/wiki/Talk:Acute_lymphoblastic_leukemia" title="Talk:Acute lymphoblastic leukemia">Discuss</a>) <small><i>Proposed since January 2015.</i></small></span></td>
</tr>
</table>
<p>The recent WHO International panel on ALL recommends that the FAB classification be abandoned, since the morphological classification has no clinical or prognostic relevance. It instead advocates the use of the immunophenotypic classification mentioned below.</p>
<dl>
<dd>1. Acute lymphoblastic leukemia/lymphoma. Synonyms: Former Fab L1/L2
<dl>
<dd>
<ul>
<li>i. <a href="/wiki/Precursor_B_acute_lymphoblastic_leukemia/lymphoma" title="Precursor B acute lymphoblastic leukemia/lymphoma" class="mw-redirect">Precursor B acute lymphoblastic leukemia/lymphoma</a>. Cytogenetic subtypes:<sup id="cite_ref-urlAdvances_in_Acute_Lymphoblastic_Leukemia_.7C_Clinical_Laboratory_Science_.7C_Find_Articles_at_BNET.com_19-0" class="reference"><a href="#cite_note-urlAdvances_in_Acute_Lymphoblastic_Leukemia_.7C_Clinical_Laboratory_Science_.7C_Find_Articles_at_BNET.com-19"><span>[</span>19<span>]</span></a></sup>
<ul>
<li>t(12;21)(p12,q22) TEL/AML-1</li>
<li>t(1;19)(q23;p13) PBX/E2A</li>
<li>t(9;22)(q34;q11) ABL/BCR</li>
<li>T(V,11)(V;q23) V/MLL</li>
</ul>
</li>
<li>ii. <a href="/wiki/Precursor_T_acute_lymphoblastic_leukemia/lymphoma" title="Precursor T acute lymphoblastic leukemia/lymphoma" class="mw-redirect">Precursor T acute lymphoblastic leukemia/lymphoma</a></li>
</ul>
</dd>
</dl>
</dd>
<dd>2. <a href="/wiki/Burkitt%27s_leukemia" title="Burkitt's leukemia" class="mw-redirect">Burkitt's leukemia</a>/lymphoma. Synonyms: Former FAB L3</dd>
<dd>3. <a href="/wiki/Biphenotypic_acute_leukemia" title="Biphenotypic acute leukemia" class="mw-redirect">Biphenotypic acute leukemia</a></dd>
</dl>
<h4><span class="mw-headline" id="Variant_features">Variant features</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=8" title="Edit section: Variant features">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<ol>
<li>Acute lymphoblastic leukemia with cytoplasmic granules</li>
<li>Aplastic presentation of ALL</li>
<li>Acute lymphoblastic leukemia with eosinophilia</li>
<li>Relapse of lymphoblastic leukemia</li>
<li>Secondary ALL</li>
</ol>
<h4><span class="mw-headline" id="Immunophenotyping">Immunophenotyping</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=9" title="Edit section: Immunophenotyping">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The use of a TdT assay and a panel of monoclonal antibodies (MoAbs) to T cell and B cell associated antigens will identify almost all cases of ALL.</p>
<p>Immunophenotypic categories of acute lymphoblastic leukemia (ALL)</p>
<table class="wikitable">
<tr>
<th>Types</th>
<th>FAB Class</th>
<th>Tdt</th>
<th>T cell associate antigen</th>
<th>B cell associate antigen</th>
<th>c Ig</th>
<th>s Ig</th>
</tr>
<tr>
<td>Precursor B</td>
<td>L1,L2</td>
<td>+</td>
<td>-</td>
<td>+</td>
<td>-/+</td>
<td>-</td>
</tr>
<tr>
<td>Precursor T</td>
<td>L1,L2</td>
<td>+</td>
<td>+</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>B-cell</td>
<td>L3</td>
<td>-</td>
<td>-</td>
<td>+</td>
<td>-</td>
<td>+</td>
</tr>
</table>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=10" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The earlier ALL is detected, the more effective the treatment. The aim is to induce a lasting <a href="/wiki/Remission_(medicine)" title="Remission (medicine)" class="mw-redirect">remission</a>, defined as the absence of detectable cancer cells in the body (usually less than 5% blast cells in the bone marrow).</p>
<p>Treatment for acute leukemia can include <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, <a href="/wiki/Steroid" title="Steroid">steroids</a>, <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, intensive combined treatments (including <a href="/wiki/Bone_marrow_transplant" title="Bone marrow transplant" class="mw-redirect">bone marrow</a> or <a href="/wiki/Stem_cell" title="Stem cell">stem cell</a> transplants), and growth factors.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Chemotherapy">Chemotherapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=11" title="Edit section: Chemotherapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Chemotherapy" title="Chemotherapy">Chemotherapy</a> is the initial treatment of choice. Most ALL patients will receive a combination of different treatments. There are no surgical options, due to the body-wide distribution of the <a href="/wiki/Malignant_cells" title="Malignant cells" class="mw-redirect">malignant cells</a>. In general, cytotoxic chemotherapy for ALL combines multiple antileukemic drugs in various combinations. Chemotherapy for ALL consists of three phases: remission induction, intensification, and maintenance therapy.</p>
<table class="wikitable">
<tr>
<th>Phase</th>
<th>Description</th>
<th>Agents</th>
</tr>
<tr>
<td>Remission induction</td>
<td>The aim of remission induction is to rapidly kill most tumor cells and get the patient into remission. This is defined as the presence of less than 5% leukemic blasts in the bone marrow, normal blood cells and absence of tumor cells from blood, and absence of other signs and symptoms of the disease. <a href="/wiki/Central_nervous_system" title="Central nervous system">Central nervous system</a> (CNS) prophylaxis should begin during this phase of treatment and continue during the consolidation/intensification period. The rationale is based on the presence of CNS involvement in 10%-40% of adult patients at diagnosis.</td>
<td>Combination of <a href="/wiki/Prednisolone" title="Prednisolone">Prednisolone</a> or <a href="/wiki/Dexamethasone" title="Dexamethasone">dexamethasone</a>, <a href="/wiki/Vincristine" title="Vincristine">vincristine</a>, <a href="/wiki/Asparaginase" title="Asparaginase">asparaginase</a> (better tolerance in pediatric patients), and <a href="/wiki/Daunorubicin" title="Daunorubicin">daunorubicin</a> (used in Adult ALL) is used to induce remission. Central nervous system prophylaxis can be achieved via irradiation, <a href="/wiki/Cytarabine" title="Cytarabine">cytarabine</a> + <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a>, or liposomal cytarabine.<sup id="cite_ref-pmid20209620_21-0" class="reference"><a href="#cite_note-pmid20209620-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>Consolidation/Intensification</td>
<td>Intensification uses high doses of intravenous multidrug chemotherapy to further reduce tumor burden. Since ALL cells sometimes penetrate the CNS, most protocols include delivery of chemotherapy into the CNS fluid (termed <a href="/wiki/Intrathecal_chemotherapy" title="Intrathecal chemotherapy" class="mw-redirect">intrathecal chemotherapy</a>). Some centers deliver the drug through <a href="/wiki/Ommaya_reservoir" title="Ommaya reservoir">Ommaya reservoir</a> (a device surgically placed under the scalp and used to deliver drugs to the CNS fluid and to extract CNS fluid for various tests). Other centers would perform multiple lumbar punctures as needed for testing and treatment delivery.</td>
<td>Typical intensification protocols use vincristine, <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, <a href="/wiki/Cytarabine" title="Cytarabine">cytarabine</a>, daunorubicin, <a href="/wiki/Etoposide" title="Etoposide">etoposide</a>, <a href="/wiki/Thioguanine" title="Thioguanine" class="mw-redirect">thioguanine</a> or <a href="/wiki/Mercaptopurine" title="Mercaptopurine">mercaptopurine</a> given as blocks in different combinations. For CNS protection, intrathecal methotrexate or cytarabine is usually used combined with or without cranio-spinal irradiation (the use of radiation therapy to the head and spine). Central nervous system relapse is treated with intrathecal administration of <a href="/wiki/Hydrocortisone" title="Hydrocortisone" class="mw-redirect">hydrocortisone</a>, methotrexate, and cytarabine.</td>
</tr>
<tr>
<td>Maintenance therapy</td>
<td>The aim of maintenance therapy is to kill any residual cell that was not killed by remission induction and intensification regimens. Although such cells are few, they will cause relapse if not eradicated.</td>
<td>For this purpose, daily oral <a href="/wiki/Mercaptopurine" title="Mercaptopurine">mercaptopurine</a>, once weekly oral <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a>, once monthly 5-day course of intravenous <a href="/wiki/Vincristine" title="Vincristine">vincristine</a> and oral corticosteroids are usually used. The length of maintenance therapy is 3 years for boys, 2 years for girls and adults.<sup id="cite_ref-HoffbrandMoss2006_22-0" class="reference"><a href="#cite_note-HoffbrandMoss2006-22"><span>[</span>22<span>]</span></a></sup></td>
</tr>
</table>
<p>As the <a href="/wiki/Chemotherapy_regimens" title="Chemotherapy regimens" class="mw-redirect">chemotherapy regimens</a> can be intensive and protracted (often about 2 years in case of the GMALL UKALL, HyperCVAD or CALGB protocols; for ALL about 3 years, 2 months for males on COG protocols; 2 years, 2 months for females - longer for males, as testicles are a potential reservoir), many patients have an <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> catheter inserted into a large vein (termed a <a href="/wiki/Central_venous_catheter" title="Central venous catheter">central venous catheter</a> or a <a href="/wiki/Hickman_line" title="Hickman line">Hickman line</a>), or a <a href="/wiki/Portacath" title="Portacath" class="mw-redirect">Portacath</a>, a cone-shaped port with a silicone nose that is surgically planted under the skin, usually near the collar bone, and the most effective product available, due to low infection risks and the long-term viability of a portacath.</p>
<h3><span class="mw-headline" id="Radiation_therapy">Radiation therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=12" title="Edit section: Radiation therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Radiation_therapy" title="Radiation therapy">Radiation therapy</a> (or radiotherapy) is used on painful bony areas, in high disease burdens, or as part of the preparations for a <a href="/wiki/Bone_marrow_transplant" title="Bone marrow transplant" class="mw-redirect">bone marrow transplant</a> (total body irradiation). Radiation in the form of whole-brain radiation is also used for central nervous system prophylaxis, to prevent recurrence of leukemia in the brain. Whole-brain prophylaxis radiation used to be a common method in treatment of children’s ALL. Recent studies showed that CNS chemotherapy provided results as favorable but with less developmental side-effects. As a result, the use of whole-brain radiation has been more limited. Most specialists in adult leukemia have abandoned the use of radiation therapy for CNS prophylaxis, instead using intrathecal chemotherapy.</p>
<h3><span class="mw-headline" id="Biological_therapy">Biological therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=13" title="Edit section: Biological therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>For some subtypes of relapsed ALL, aiming at biological targets such as the proteasome, in combination with chemotherapy, has given promising results in clinical trials.<sup id="cite_ref-pmid22653976_23-0" class="reference"><a href="#cite_note-pmid22653976-23"><span>[</span>23<span>]</span></a></sup> Selection of biological targets on the basis of their combinatorial effects on the leukemic lymphoblasts can lead to clinical trials for improvement in the effects of ALL treatment.<sup id="cite_ref-pmid22273806_24-0" class="reference"><a href="#cite_note-pmid22273806-24"><span>[</span>24<span>]</span></a></sup> In ongoing clinical trials, a CD19-CD3 bi-specific monoclonal murine antibody - <a href="/wiki/Blinatumomab" title="Blinatumomab">Blinatumomab</a>, is showing great promise.</p>
<h3><span class="mw-headline" id="Immunotherapy">Immunotherapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=14" title="Edit section: Immunotherapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Chimeric_antigen_receptor" title="Chimeric antigen receptor">Chimeric antigen receptors</a> (CARs) have been developed as a promising therapy for ALL. This technology uses a <a href="/wiki/Single_chain_variable_fragment" title="Single chain variable fragment" class="mw-redirect">single chain variable fragment</a> (scFv) designed to recognize the cell surface marker <a href="/wiki/CD19" title="CD19">CD19</a> as a method of treating ALL. CD19 is a molecule found on all B-cells and can be used as a means of distinguishing the potentially malignant B-cell population in the patient. In this therapy, mice are immunized with the CD19 antigen and produce anti-CD19 antibodies. Hybridomas developed from the mouse spleen cells fused to a myeloma cell line can be developed as a source for the cDNA encoding the CD19 specific antibody.<sup id="cite_ref-pmid23527958_25-0" class="reference"><a href="#cite_note-pmid23527958-25"><span>[</span>25<span>]</span></a></sup> The cDNA is sequenced and the sequence encoding the variable heavy and variable light chains of these antibodies are cloned together using a small peptide linker. This resulting sequence encodes the scFv. This can be cloned into a transgene encoding what will become the endodomain of the CAR. There are varying arrangements of subunits used as the endodomain but they generally consist of the hinge region that attaches to the scFv, a transmembrane region, the intracellular region of a costimulatory molecule such as CD28, and the intracellular domain of CD3-zeta containing ITAM repeats. Other sequences frequently included are: 4-1bb and OX40.<sup id="cite_ref-Barrett_2014_26-0" class="reference"><a href="#cite_note-Barrett_2014-26"><span>[</span>26<span>]</span></a></sup> The final transgene sequence, containing the scFv and endodomain sequences is then inserted into immune effector cells that are obtained from the patient and expanded in vitro. In previous trials these have been a type of T-cell capable of cytotoxicity.<sup id="cite_ref-pmid23695536_27-0" class="reference"><a href="#cite_note-pmid23695536-27"><span>[</span>27<span>]</span></a></sup> Inserting the DNA into the effector cell can be accomplished by several methods. Most commonly, this is done using a lentivirus which encodes the transgene. Pseudotyped, self-inactivating lentiviruses have been shown to be an effective method for the stable insertion of a desired transgene into the target cell genomic DNA.<sup id="cite_ref-pmid9811723_28-0" class="reference"><a href="#cite_note-pmid9811723-28"><span>[</span>28<span>]</span></a></sup> Other methods include electroporation and transfection but these are limited in their efficacy as transgene expression will diminish over time. The gene-modified effector cells are then transplanted back into the patient. Typically this process is done in conjunction with a conditioning regiment such as cyclophosphamide which has been shown to potentiate the effects of infused T-cells. This effect has been attributed to the creation of an immunologic space niche.<sup id="cite_ref-Barrett_2014_26-1" class="reference"><a href="#cite_note-Barrett_2014-26"><span>[</span>26<span>]</span></a></sup> The process as a whole results in an effector cell, typically a T-cell, that can recognize a tumor cell antigen in a major histocompatibility complex independent manner and initiate a cytotoxic response</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=15" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The 5-year survival rate has improved from zero six decades ago, to 85% currently, largely due to <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trials</a> on new chemotherapeutic agents and improvements in <a href="/wiki/Stem_cell_transplantation" title="Stem cell transplantation" class="mw-redirect">stem cell transplantation</a> (SCT) technology.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup></p>
<p>Five-year survival rates evaluate older, not current, treatments. New drugs, and matching treatment to the genetic characteristics of the blast cells, may improve those rates. The prognosis for ALL differs between individuals depending on a variety of factors:<sup id="cite_ref-PMSR_1-4" class="reference"><a href="#cite_note-PMSR-1"><span>[</span>1<span>]</span></a></sup></p>
<ul>
<li>Gender: females tend to fare better than males.</li>
<li>Ethnicity: <a href="/wiki/Whites" title="Whites" class="mw-redirect">Caucasians</a> are more likely to develop acute leukemia than <a href="/wiki/African_American" title="African American">African-Americans</a>, <a href="/wiki/Asian_American" title="Asian American">Asians</a> or <a href="/wiki/Hispanics_in_the_United_States" title="Hispanics in the United States" class="mw-redirect">Hispanics</a>. However, they also tend to have a better prognosis than non-Caucasians.</li>
<li>Age at diagnosis: children between 1–10 years of age are most likely to develop ALL and to be cured of it. Cases in older patients are more likely to result from chromosomal abnormalities (e.g., the Philadelphia chromosome) that make treatment more difficult and prognoses poorer.</li>
<li>White blood cell count at diagnosis of less than 50,000/µl</li>
<li>Cancer spread into the <a href="/wiki/Central_nervous_system" title="Central nervous system">Central nervous system</a> (<a href="/wiki/Brain" title="Brain">brain</a> or <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a>) has worse outcomes.</li>
<li>Morphological, immunological, and genetic subtypes</li>
<li>Patient's response to initial treatment</li>
<li><a href="/wiki/Genetic_disorder" title="Genetic disorder">Genetic disorders</a> such as <a href="/wiki/Down_syndrome" title="Down syndrome">Down's Syndrome</a></li>
</ul>
<p><a href="/wiki/Cytogenetics" title="Cytogenetics">Cytogenetics</a>, the study of characteristic large changes in the <a href="/wiki/Chromosomes" title="Chromosomes" class="mw-redirect">chromosomes</a> of <a href="/wiki/Cancer_cell" title="Cancer cell">cancer cells</a>, is an important predictor of outcome.<sup id="cite_ref-pmid17170120_30-0" class="reference"><a href="#cite_note-pmid17170120-30"><span>[</span>30<span>]</span></a></sup></p>
<p>Some cytogenetic subtypes have a worse prognosis than others. These include:<sup id="cite_ref-AMSR_2-8" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<ul>
<li>A translocation between <a href="/wiki/Chromosome" title="Chromosome">chromosomes</a> 9 and 22, known as the <a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a>, occurs in about 20% of adult and 5% in pediatric cases of ALL.</li>
<li>A translocation between chromosomes 4 and 11 occurs in about 4% of cases and is most common in infants under 12 months.</li>
<li>Not all translocations of chromosomes carry a poorer prognosis. Some translocations are relatively favorable. For example, Hyperdiploidy (&gt;50 chromosomes) is a good prognostic factor.</li>
<li>Genome-wide copy number changes can be assessed by conventional cytogenetics or <a href="/wiki/Virtual_Karyotype" title="Virtual Karyotype" class="mw-redirect">virtual karyotyping</a>. SNP array virtual karyotyping can detect copy number changes and LOH status, while arrayCGH can detect only copy number changes. Copy neutral LOH (acquired uniparental disomy) has been reported at key loci in ALL, such as CDKN2A gene, which have prognostic significance.<sup id="cite_ref-pmid17890455_31-0" class="reference"><a href="#cite_note-pmid17890455-31"><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-pmid18803328_32-0" class="reference"><a href="#cite_note-pmid18803328-32"><span>[</span>32<span>]</span></a></sup><sup id="cite_ref-pmid18838613_33-0" class="reference"><a href="#cite_note-pmid18838613-33"><span>[</span>33<span>]</span></a></sup> SNP array<a href="/wiki/Virtual_Karyotype" title="Virtual Karyotype" class="mw-redirect">virtual karyotyping</a> can readily detect copy neutral LOH. Array CGH, FISH, and conventional cytogenetics cannot detect copy neutral LOH.</li>
</ul>
<table class="wikitable">
<tr>
<th>Cytogenetic change</th>
<th>Risk category</th>
</tr>
<tr>
<td><a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a></td>
<td>Poor prognosis</td>
</tr>
<tr>
<td>t(4;11)(q21;q23)</td>
<td>Poor prognosis</td>
</tr>
<tr>
<td>t(8;14)(q24.1;q32)</td>
<td>Poor prognosis</td>
</tr>
<tr>
<td>Complex <a href="/wiki/Karyotype" title="Karyotype">karyotype</a> (more than four abnormalities)</td>
<td>Poor prognosis</td>
</tr>
<tr>
<td>Low <a href="/w/index.php?title=Hypodiploidy&amp;action=edit&amp;redlink=1" class="new" title="Hypodiploidy (page does not exist)">hypodiploidy</a> or near <a href="/wiki/Triploidy" title="Triploidy" class="mw-redirect">triploidy</a></td>
<td>Poor prognosis</td>
</tr>
<tr>
<td>High <a href="/w/index.php?title=Hyperdiploidy&amp;action=edit&amp;redlink=1" class="new" title="Hyperdiploidy (page does not exist)">hyperdiploidy</a> (specifically, trisomy 4, 10, 17)</td>
<td>Good prognosis</td>
</tr>
<tr>
<td>del(9p)</td>
<td>Good prognosis</td>
</tr>
</table>
<p><b>Correlation of prognosis with bone marrow cytogenetic finding in acute lymphoblastic leukemia</b></p>
<table class="wikitable">
<tr>
<th>Prognosis</th>
<th>Cytogenetic findings</th>
</tr>
<tr>
<td>Favorable</td>
<td>Hyperdiploidy &gt; 50&#160;; t (12;21)</td>
</tr>
<tr>
<td>Intermediate</td>
<td>Hyperdiploidy 47 -50; Normal(diploidy); del (6q); Rearrangements of 8q24</td>
</tr>
<tr>
<td>Unfavorable</td>
<td>Hypodiploidy-near haploidy; Near tetraploidy; del (17p); t (9;22); t (11q23)</td>
</tr>
</table>
<p>Unclassified ALL is considered to have an intermediate prognosis.<sup id="cite_ref-pmid19138562_34-0" class="reference"><a href="#cite_note-pmid19138562-34"><span>[</span>34<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=16" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="United_States">United States</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=17" title="Edit section: United States">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the US, the incidence of ALL is roughly 3000-3500 or approximately 1 in 50,000.<sup id="cite_ref-PMSR_1-5" class="reference"><a href="#cite_note-PMSR-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-AMSR_2-9" class="reference"><a href="#cite_note-AMSR-2"><span>[</span>2<span>]</span></a></sup> ALL is slightly more common in males than females. In the United States in 2010, <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> in ages birth to 19 was 38.4 per 1,000,000 per year in boys and 30.2 per 1,000,000 per year in girls.<sup id="cite_ref-ACS_2014_Stats_35-0" class="reference"><a href="#cite_note-ACS_2014_Stats-35"><span>[</span>35<span>]</span></a></sup> <a href="/wiki/Prevalence" title="Prevalence">Prevalence</a> was 30,171, and observed survival was 90% (based on data from 2003-2009). ALL has a bimodal age distribution, having a high incidence in ages 2–5 and another peak in incidence above 50 years old. There is an increased incidence in people with <a href="/wiki/Down_Syndrome" title="Down Syndrome" class="mw-redirect">Down Syndrome</a>, <a href="/wiki/Fanconi_anemia" title="Fanconi anemia">Fanconi anemia</a>, <a href="/wiki/Bloom_syndrome" title="Bloom syndrome">Bloom syndrome</a>, <a href="/wiki/Ataxia_telangiectasia" title="Ataxia telangiectasia">Ataxia telangiectasia</a>, <a href="/wiki/X-linked_agammaglobulinemia" title="X-linked agammaglobulinemia">X-linked agammaglobulinemia</a>, and <a href="/wiki/Severe_combined_immunodeficiency" title="Severe combined immunodeficiency">Severe combined immunodeficiency</a>. There is an increased risk in people with a family history of <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmune diseases</a>, particularly autoimmune thyroid diseases (namely <a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a> or <a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's thyroiditis</a>).<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="United_Kingdom">United Kingdom</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=18" title="Edit section: United Kingdom">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>ALL accounts for 8% of all leukaemia cases in the UK, and around 650 people were diagnosed with the disease in 2011.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pregnancy">Pregnancy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=19" title="Edit section: Pregnancy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Leukemia is rarely associated with pregnancy, affecting only about 1 in 10,000 pregnant women.<sup id="cite_ref-Shapira_38-0" class="reference"><a href="#cite_note-Shapira-38"><span>[</span>38<span>]</span></a></sup> How it is handled depends primarily on the type of leukemia. Acute leukemias normally require prompt, aggressive treatment, despite significant risks of <a href="/wiki/Pregnancy_loss" title="Pregnancy loss" class="mw-redirect">pregnancy loss</a> and <a href="/wiki/Birth_defect" title="Birth defect" class="mw-redirect">birth defects</a>, especially if chemotherapy is given during the developmentally sensitive <a href="/wiki/First_trimester" title="First trimester" class="mw-redirect">first trimester</a>.<sup id="cite_ref-Shapira_38-1" class="reference"><a href="#cite_note-Shapira-38"><span>[</span>38<span>]</span></a></sup></p>
<p>It is possible, although extremely rare, for leukemia to spread from mother to the child.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup> This is called <a href="/wiki/Vertical_transmission" title="Vertical transmission" class="mw-redirect">vertical transmission</a>.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=20" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-PMSR-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-PMSR_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PMSR_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-PMSR_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-PMSR_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-PMSR_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-PMSR_1-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Weinblatt, ME (10 July 2013). Sakamoto, KM; Windle, ML; Cripe, TP; Arceci, RJ, ed. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/987228-overview#showall">"Pediatric Acute Myelocytic Leukemia"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">17 April</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Pediatric+Acute+Myelocytic+Leukemia&amp;rft.aulast=Weinblatt%2C+ME&amp;rft.au=Weinblatt%2C+ME&amp;rft.date=10+July+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F987228-overview%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AMSR-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-AMSR_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AMSR_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AMSR_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AMSR_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AMSR_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AMSR_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AMSR_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AMSR_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AMSR_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-AMSR_2-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Seiter, K (5 February 2014). Sarkodee-Adoo, C; Talavera, F; Sacher, RA; Besa, EC, ed. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/207631-overview#showall">"Acute Lymphoblastic Leukemia"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">17 April</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Acute+Lymphoblastic+Leukemia&amp;rft.aulast=Seiter%2C+K&amp;rft.au=Seiter%2C+K&amp;rft.date=5+February+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F207631-overview%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation journal">Inaba H, Greaves M, Mullighan CG (June 2013). <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816716/pdf/nihms517584.pdf">"Acute lymphoblastic leukaemia."</a> <span style="font-size:85%;">(PDF)</span>. <i>Lancet</i> <b>381</b> (9881): 1943–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2812%2962187-4">10.1016/S0140-6736(12)62187-4</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3816716">3816716</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23523389">23523389</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Acute+lymphoblastic+leukaemia.&amp;rft.au=Inaba+H%2C+Greaves+M%2C+Mullighan+CG&amp;rft.aulast=Inaba+H%2C+Greaves+M%2C+Mullighan+CG&amp;rft.date=June+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3816716%2Fpdf%2Fnihms517584.pdf&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2812%2962187-4&amp;rft_id=info%3Apmc%2F3816716&amp;rft_id=info%3Apmid%2F23523389&amp;rft.issue=9881&amp;rft.jtitle=Lancet&amp;rft.pages=1943-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=381" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MM-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-MM_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MM_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Rytting, ME, ed. (November 2013). <a rel="nofollow" class="external text" href="http://www.merckmanuals.com/professional/hematology_and_oncology/leukemias/acute_leukemia.html">"Acute Leukemia"</a>. <i>Merck Manual Professional</i>. Merck Sharp &amp; Dohme Corp<span class="reference-accessdate">. Retrieved <span class="nowrap">17 April</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Acute+Leukemia&amp;rft.date=November+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.merckmanuals.com%2Fprofessional%2Fhematology_and_oncology%2Fleukemias%2Facute_leukemia.html&amp;rft.jtitle=Merck+Manual+Professional&amp;rft.pub=Merck+Sharp+%26+Dohme+Corp.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Harrison-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Harrison_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Harrison_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Longo, D (2011). "Chapter 110: Malignancies of Lymphoid Cells". <i>Harrison's Principles of Internal Medicine</i> (18 ed.). New York: McGraw-Hill Professional. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-07174889-6" title="Special:BookSources/978-0-07174889-6">978-0-07174889-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Chapter+110%3A+Malignancies+of+Lymphoid+Cells&amp;rft.aufirst=D&amp;rft.aulast=Longo&amp;rft.au=Longo%2C+D&amp;rft.btitle=Harrison%27s+Principles+of+Internal+Medicine&amp;rft.date=2011&amp;rft.edition=18&amp;rft.genre=bookitem&amp;rft.isbn=978-0-07174889-6&amp;rft.place=New+York&amp;rft.pub=McGraw-Hill+Professional&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.org/acs/groups/cid/documents/webcontent/002048-pdf.pdf">"Evolution of cancer treatments: Chemotherapy"</a> <span style="font-size:85%;">(PDF)</span>. <i>Cancer.org</i>. American Cancer Society. 8 June 2012.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Evolution+of+cancer+treatments%3A+Chemotherapy&amp;rft.date=8+June+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2Facs%2Fgroups%2Fcid%2Fdocuments%2Fwebcontent%2F002048-pdf.pdf&amp;rft.jtitle=Cancer.org&amp;rft.pub=American+Cancer+Society&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-malady-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-malady_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-malady_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Mukherjee, Siddhartha (2010). <i>The Emperor of all Maladies: a Biography of Cancer</i> (1st Scribner hardcover ed. ed.). New York: Scribner. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4391-0795-9" title="Special:BookSources/978-1-4391-0795-9">978-1-4391-0795-9</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.aufirst=Siddhartha&amp;rft.aulast=Mukherjee&amp;rft.au=Mukherjee%2C+Siddhartha&amp;rft.btitle=The+Emperor+of+all+Maladies%3A+a+Biography+of+Cancer&amp;rft.date=2010&amp;rft.edition=1st+Scribner+hardcover+ed.&amp;rft.genre=book&amp;rft.isbn=978-1-4391-0795-9&amp;rft.place=New+York&amp;rft.pub=Scribner&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.org/cancer/leukemia-acutelymphocyticallinadults/detailedguide/leukemia-acute-lymphocytic-risk-factors">"Leukemia--Acute Lymphocytic"</a>. American Cancer Society<span class="reference-accessdate">. Retrieved <span class="nowrap">8 February</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.btitle=Leukemia--Acute+Lymphocytic&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2Fcancer%2Fleukemia-acutelymphocyticallinadults%2Fdetailedguide%2Fleukemia-acute-lymphocytic-risk-factors&amp;rft.pub=American+Cancer+Society&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-smith-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-smith_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land VJ, Miser J, Shuster J, Vena D (Feb 1999). <a rel="nofollow" class="external text" href="http://jco.ascopubs.org/cgi/reprint/17/2/569">"Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins"</a> <span style="font-size:85%;">(PDF)</span>. <i>Journal of Clinical Oncology</i> (American Society for Clinical Oncology) <b>17</b> (2): 569–77. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10080601">10080601</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Secondary+Leukemia+or+Myelodysplastic+Syndrome+After+Treatment+With+Epipodophyllotoxins&amp;rft.aulast=Smith+MA%2C+Rubinstein+L%2C+Anderson+JR%2C+Arthur+D%2C+Catalano+PJ%2C+Freidlin+B%2C+Heyn+R%2C+Khayat+A%2C+Krailo+M%2C+Land+VJ%2C+Miser+J%2C+Shuster+J%2C+Vena+D&amp;rft.au=Smith+MA%2C+Rubinstein+L%2C+Anderson+JR%2C+Arthur+D%2C+Catalano+PJ%2C+Freidlin+B%2C+Heyn+R%2C+Khayat+A%2C+Krailo+M%2C+Land+VJ%2C+Miser+J%2C+Shuster+J%2C+Vena+D&amp;rft.date=Feb+1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Freprint%2F17%2F2%2F569&amp;rft_id=info%3Apmid%2F10080601&amp;rft.issue=2&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.pages=569-77&amp;rft.pub=American+Society+for+Clinical+Oncology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation book">Collier, J.A.B (1991). <i>Oxford Handbook of Clinical Specialties, Third Edition</i>. Oxford. p.&#160;810. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-19-262116-5" title="Special:BookSources/0-19-262116-5">0-19-262116-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.au=Collier%2C+J.A.B&amp;rft.aufirst=J.A.B&amp;rft.aulast=Collier&amp;rft.btitle=Oxford+Handbook+of+Clinical+Specialties%2C+Third+Edition&amp;rft.date=1991&amp;rft.genre=book&amp;rft.isbn=0-19-262116-5&amp;rft.pages=810&amp;rft.pub=Oxford&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15837750-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15837750_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R (April 2005). <a rel="nofollow" class="external text" href="http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=15837750">"Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia"</a>. <i>Clin. Cancer Res.</i> <b>11</b> (8): 2974–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F1078-0432.CCR-04-1829">10.1158/1078-0432.CCR-04-1829</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15837750">15837750</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Expression+levels+of+TEL%2C+AML1%2C+and+the+fusion+products+TEL-AML1+and+AML1-TEL+versus+drug+sensitivity+and+clinical+outcome+in+t%2812%3B21%29-positive+pediatric+acute+lymphoblastic+leukemia&amp;rft.aulast=Stams+WA%2C+den+Boer+ML%2C+Beverloo+HB%2C+Meijerink+JP%2C+van+Wering+ER%2C+Janka-Schaub+GE%2C+Pieters+R&amp;rft.au=Stams+WA%2C+den+Boer+ML%2C+Beverloo+HB%2C+Meijerink+JP%2C+van+Wering+ER%2C+Janka-Schaub+GE%2C+Pieters+R&amp;rft.date=April+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fclincancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D15837750&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-04-1829&amp;rft_id=info%3Apmid%2F15837750&amp;rft.issue=8&amp;rft.jtitle=Clin.+Cancer+Res.&amp;rft.pages=2974-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18665825-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18665825_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18665825_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18665825_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18665825_12-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Pakakasama S, Kajanachumpol S, Kanjanapongkul S, Sirachainan N, Meekaewkunchorn A, Ningsanond V, Hongeng S (August 2008). "Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia". <i>Int J Lab Hematol</i> <b>30</b> (4): 286–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1751-553X.2007.00954.x">10.1111/j.1751-553X.2007.00954.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18665825">18665825</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Simple+multiplex+RT-PCR+for+identifying+common+fusion+transcripts+in+childhood+acute+leukemia&amp;rft.aulast=Pakakasama+S%2C+Kajanachumpol+S%2C+Kanjanapongkul+S%2C+Sirachainan+N%2C+Meekaewkunchorn+A%2C+Ningsanond+V%2C+Hongeng+S&amp;rft.au=Pakakasama+S%2C+Kajanachumpol+S%2C+Kanjanapongkul+S%2C+Sirachainan+N%2C+Meekaewkunchorn+A%2C+Ningsanond+V%2C+Hongeng+S&amp;rft.date=August+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1751-553X.2007.00954.x&amp;rft_id=info%3Apmid%2F18665825&amp;rft.issue=4&amp;rft.jtitle=Int+J+Lab+Hematol&amp;rft.pages=286-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10500199-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10500199_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C (September 1999). <a rel="nofollow" class="external text" href="http://www.pnas.org/cgi/pmidlookup?view=long&amp;pmid=10500199">"Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia"</a>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>96</b> (20): 11464–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.96.20.11464">10.1073/pnas.96.20.11464</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC18056">18056</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10500199">10500199</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Oncogenic+homeodomain+transcription+factor+E2A-Pbx1+activates+a+novel+WNT+gene+in+pre-B+acute+lymphoblastoid+leukemia&amp;rft.aulast=McWhirter+JR%2C+Neuteboom+ST%2C+Wancewicz+EV%2C+Monia+BP%2C+Downing+JR%2C+Murre+C&amp;rft.au=McWhirter+JR%2C+Neuteboom+ST%2C+Wancewicz+EV%2C+Monia+BP%2C+Downing+JR%2C+Murre+C&amp;rft.date=September+1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.pnas.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10500199&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.96.20.11464&amp;rft_id=info%3Apmc%2F18056&amp;rft_id=info%3Apmid%2F10500199&amp;rft.issue=20&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.pages=11464-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=96" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16080957-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16080957_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rudolph C, Hegazy AN, von Neuhoff N, Steinemann D, Schröck E, Stripecke R, Klein C, Schlegelberger B (August 2005). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0165-4608(05)00019-1">"Cytogenetic characterization of a BCR-ABL transduced mouse cell line"</a>. <i>Cancer Genet. Cytogenet.</i> <b>161</b> (1): 51–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.cancergencyto.2004.12.021">10.1016/j.cancergencyto.2004.12.021</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16080957">16080957</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Cytogenetic+characterization+of+a+BCR-ABL+transduced+mouse+cell+line&amp;rft.aulast=Rudolph+C%2C+Hegazy+AN%2C+von+Neuhoff+N%2C+Steinemann+D%2C+Schr%C3%B6ck+E%2C+Stripecke+R%2C+Klein+C%2C+Schlegelberger+B&amp;rft.au=Rudolph+C%2C+Hegazy+AN%2C+von+Neuhoff+N%2C+Steinemann+D%2C+Schr%C3%B6ck+E%2C+Stripecke+R%2C+Klein+C%2C+Schlegelberger+B&amp;rft.date=August+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0165-4608%2805%2900019-1&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cancergencyto.2004.12.021&amp;rft_id=info%3Apmid%2F16080957&amp;rft.issue=1&amp;rft.jtitle=Cancer+Genet.+Cytogenet.&amp;rft.pages=51-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=161" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid14990976-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14990976_15-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Caslini C, Serna A, Rossi V, Introna M, Biondi A (June 2004). "Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein". <i>Leukemia</i> <b>18</b> (6): 1064–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.leu.2403321">10.1038/sj.leu.2403321</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14990976">14990976</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Modulation+of+cell+cycle+by+graded+expression+of+MLL-AF4+fusion+oncoprotein&amp;rft.au=Caslini+C%2C+Serna+A%2C+Rossi+V%2C+Introna+M%2C+Biondi+A&amp;rft.aulast=Caslini+C%2C+Serna+A%2C+Rossi+V%2C+Introna+M%2C+Biondi+A&amp;rft.date=June+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.leu.2403321&amp;rft_id=info%3Apmid%2F14990976&amp;rft.issue=6&amp;rft.jtitle=Leukemia&amp;rft.pages=1064-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15852472-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15852472_16-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Martín-Subero JI, Odero MD, Hernandez R, Cigudosa JC, Agirre X, Saez B, Sanz-García E, Ardanaz MT, Novo FJ, Gascoyne RD, Calasanz MJ, Siebert R (August 2005). "Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas". <i>Genes Chromosomes Cancer</i> <b>43</b> (4): 414–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fgcc.20187">10.1002/gcc.20187</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15852472">15852472</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Amplification+of+IGH%2FMYC+fusion+in+clinically+aggressive+IGH%2FBCL2-positive+germinal+center+B-cell+lymphomas&amp;rft.aulast=Mart%C3%ADn-Subero+JI%2C+Odero+MD%2C+Hernandez+R%2C+Cigudosa+JC%2C+Agirre+X%2C+Saez+B%2C+Sanz-Garc%C3%ADa+E%2C+Ardanaz+MT%2C+Novo+FJ%2C+Gascoyne+RD%2C+Calasanz+MJ%2C+Siebert+R&amp;rft.au=Mart%C3%ADn-Subero+JI%2C+Odero+MD%2C+Hernandez+R%2C+Cigudosa+JC%2C+Agirre+X%2C+Saez+B%2C+Sanz-Garc%C3%ADa+E%2C+Ardanaz+MT%2C+Novo+FJ%2C+Gascoyne+RD%2C+Calasanz+MJ%2C+Siebert+R&amp;rft.date=August+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fgcc.20187&amp;rft_id=info%3Apmid%2F15852472&amp;rft.issue=4&amp;rft.jtitle=Genes+Chromosomes+Cancer&amp;rft.pages=414-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid7497440-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7497440_17-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zalcberg IQ, Silva ML, Abdelhay E, Tabak DG, Ornellas MH, Simões FV, Pucheri W, Ribeiro R, Seuánez HN (October 1995). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/0165460895000623">"Translocation 11;14 in three children with acute lymphoblastic leukemia of T-cell origin"</a>. <i>Cancer Genet. Cytogenet.</i> <b>84</b> (1): 32–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0165-4608%2895%2900062-3">10.1016/0165-4608(95)00062-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7497440">7497440</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Translocation+11%3B14+in+three+children+with+acute+lymphoblastic+leukemia+of+T-cell+origin&amp;rft.aulast=Zalcberg+IQ%2C+Silva+ML%2C+Abdelhay+E%2C+Tabak+DG%2C+Ornellas+MH%2C+Sim%C3%B5es+FV%2C+Pucheri+W%2C+Ribeiro+R%2C+Seu%C3%A1nez+HN&amp;rft.au=Zalcberg+IQ%2C+Silva+ML%2C+Abdelhay+E%2C+Tabak+DG%2C+Ornellas+MH%2C+Sim%C3%B5es+FV%2C+Pucheri+W%2C+Ribeiro+R%2C+Seu%C3%A1nez+HN&amp;rft.date=October+1995&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2F0165460895000623&amp;rft_id=info%3Adoi%2F10.1016%2F0165-4608%2895%2900062-3&amp;rft_id=info%3Apmid%2F7497440&amp;rft.issue=1&amp;rft.jtitle=Cancer+Genet.+Cytogenet.&amp;rft.pages=32-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=84" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlACS_::_How_Is_Acute_Lymphocytic_Leukemia_Classified.3F-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlACS_::_How_Is_Acute_Lymphocytic_Leukemia_Classified.3F_18-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_How_Is_Acute_Lymphocytic_Leukemia_Classified.asp?rnav=cri">"ACS&#160;:: How Is Acute Lymphocytic Leukemia Classified?"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.btitle=ACS+%3A%3A+How+Is+Acute+Lymphocytic+Leukemia+Classified%3F&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2Fdocroot%2FCRI%2Fcontent%2FCRI_2_4_3X_How_Is_Acute_Lymphocytic_Leukemia_Classified.asp%3Frnav%3Dcri&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlAdvances_in_Acute_Lymphoblastic_Leukemia_.7C_Clinical_Laboratory_Science_.7C_Find_Articles_at_BNET.com-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlAdvances_in_Acute_Lymphoblastic_Leukemia_.7C_Clinical_Laboratory_Science_.7C_Find_Articles_at_BNET.com_19-0">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://findarticles.com/p/articles/mi_qa3890/is_200410/ai_n9429273/pg_2">"Advances in Acute Lymphoblastic Leukemia | Clinical Laboratory Science | Find Articles at BNET.com"</a>. <i>Clinical Laboratory Science</i>. 2004.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Advances+in+Acute+Lymphoblastic+Leukemia+%26%23124%3B+Clinical+Laboratory+Science+%26%23124%3B+Find+Articles+at+BNET.com&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Ffindarticles.com%2Fp%2Farticles%2Fmi_qa3890%2Fis_200410%2Fai_n9429273%2Fpg_2&amp;rft.jtitle=Clinical+Laboratory+Science&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.mountsinai.org/patient-care/health-library/diseases-and-conditions/acute-lymphoblastic-leukemia">Acute lymphoblastic leukemia</a> at <a href="/wiki/Mount_Sinai_Hospital,_New_York" title="Mount Sinai Hospital, New York" class="mw-redirect">Mount Sinai Hospital</a></span></li>
<li id="cite_note-pmid20209620-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20209620_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jabbour E, Thomas D, Cortes J, Kantarjian HM, O'Brien S (May 15, 2010). "Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies.". <i>Cancer</i> <b>116</b> (10): 2290–300. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.25008">10.1002/cncr.25008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20209620">20209620</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Central+nervous+system+prophylaxis+in+adults+with+acute+lymphoblastic+leukemia%3A+current+and+emerging+therapies.&amp;rft.au=Jabbour+E%2C+Thomas+D%2C+Cortes+J%2C+Kantarjian+HM%2C+O%27Brien+S&amp;rft.aulast=Jabbour+E%2C+Thomas+D%2C+Cortes+J%2C+Kantarjian+HM%2C+O%27Brien+S&amp;rft.date=May+15%2C+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.25008&amp;rft_id=info%3Apmid%2F20209620&amp;rft.issue=10&amp;rft.jtitle=Cancer&amp;rft.pages=2290-300&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=116" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-HoffbrandMoss2006-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-HoffbrandMoss2006_22-0">^</a></b></span> <span class="reference-text"><span class="citation book">Hoffbrand, Victor; Moss, Paul; Pettit, John (31 October 2006). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=IFFL_1YNy_oC"><i>Essential Haematology</i></a>. Wiley. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4051-3649-5" title="Special:BookSources/978-1-4051-3649-5">978-1-4051-3649-5</a><span class="reference-accessdate">. Retrieved <span class="nowrap">14 September</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.aufirst=Victor&amp;rft.au=Hoffbrand%2C+Victor&amp;rft.aulast=Hoffbrand&amp;rft.au=Moss%2C+Paul&amp;rft.au=Pettit%2C+John&amp;rft.btitle=Essential+Haematology&amp;rft.date=31+October+2006&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DIFFL_1YNy_oC&amp;rft.isbn=978-1-4051-3649-5&amp;rft.pub=Wiley&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid22653976-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22653976_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Messinger YH, Gaynon PS, Sposto R, van der Giessen J, Eckroth E, Malvar J, Bostrom BC (July 2012). <a rel="nofollow" class="external text" href="http://bloodjournal.hematologylibrary.org/content/120/2/285.long">"Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia &amp; Lymphoma (TACL) Study"</a>. <i>Blood.</i> <b>120</b> (2): 285–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2012-04-418640">10.1182/blood-2012-04-418640</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22653976">22653976</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Bortezomib+with+chemotherapy+is+highly+active+in+advanced+B-precursor+acute+lymphoblastic+leukemia%3A+Therapeutic+Advances+in+Childhood+Leukemia+%26+Lymphoma+%28TACL%29+Study&amp;rft.aulast=Messinger+YH%2C+Gaynon+PS%2C+Sposto+R%2C+van+der+Giessen+J%2C+Eckroth+E%2C+Malvar+J%2C+Bostrom+BC&amp;rft.au=Messinger+YH%2C+Gaynon+PS%2C+Sposto+R%2C+van+der+Giessen+J%2C+Eckroth+E%2C+Malvar+J%2C+Bostrom+BC&amp;rft.date=July+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcontent%2F120%2F2%2F285.long&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2012-04-418640&amp;rft_id=info%3Apmid%2F22653976&amp;rft.issue=2&amp;rft.jtitle=Blood.&amp;rft.pages=285-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid22273806-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22273806_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lambrou GI, Papadimitriou L, Chrousos GP, Vlahopoulos SA (January 2012). "Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: multiple, diverse signals converging on a few key downstream regulators". <i>Mol Cell Endocrinol.</i> <b>351</b> (2): 142–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.mce.2012.01.003">10.1016/j.mce.2012.01.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22273806">22273806</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Glucocorticoid+and+proteasome+inhibitor+impact+on+the+leukemic+lymphoblast%3A+multiple%2C+diverse+signals+converging+on+a+few+key+downstream+regulators&amp;rft.au=Lambrou+GI%2C+Papadimitriou+L%2C+Chrousos+GP%2C+Vlahopoulos+SA&amp;rft.aulast=Lambrou+GI%2C+Papadimitriou+L%2C+Chrousos+GP%2C+Vlahopoulos+SA&amp;rft.date=January+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mce.2012.01.003&amp;rft_id=info%3Apmid%2F22273806&amp;rft.issue=2&amp;rft.jtitle=Mol+Cell+Endocrinol.&amp;rft.pages=142-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=351" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid23527958-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23527958_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4058440">"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia"</a>. <i>N. Engl. J. Med.</i> <b>368</b> (16): 1509–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1215134">10.1056/NEJMoa1215134</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4058440">4058440</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23527958">23527958</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Chimeric+antigen+receptor-modified+T+cells+for+acute+lymphoid+leukemia&amp;rft.au=Grupp+SA%2C+Kalos+M%2C+Barrett+D%2C+Aplenc+R%2C+Porter+DL%2C+Rheingold+SR%2C+Teachey+DT%2C+Chew+A%2C+Hauck+B%2C+Wright+JF%2C+Milone+MC%2C+Levine+BL%2C+June+CH&amp;rft.aulast=Grupp+SA%2C+Kalos+M%2C+Barrett+D%2C+Aplenc+R%2C+Porter+DL%2C+Rheingold+SR%2C+Teachey+DT%2C+Chew+A%2C+Hauck+B%2C+Wright+JF%2C+Milone+MC%2C+Levine+BL%2C+June+CH&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4058440&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1215134&amp;rft_id=info%3Apmc%2F4058440&amp;rft_id=info%3Apmid%2F23527958&amp;rft.issue=16&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1509-18&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=368" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Barrett_2014-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-Barrett_2014_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Barrett_2014_26-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Barrett DM, Singh N, Porter DL, Grupp SA, June CH (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4120077">"Chimeric antigen receptor therapy for cancer"</a>. <i>Annu. Rev. Med.</i> <b>65</b>: 333–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1146%2Fannurev-med-060512-150254">10.1146/annurev-med-060512-150254</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4120077">4120077</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24274181">24274181</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Chimeric+antigen+receptor+therapy+for+cancer&amp;rft.au=Barrett+DM%2C+Singh+N%2C+Porter+DL%2C+Grupp+SA%2C+June+CH&amp;rft.aulast=Barrett+DM%2C+Singh+N%2C+Porter+DL%2C+Grupp+SA%2C+June+CH&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4120077&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-med-060512-150254&amp;rft_id=info%3Apmc%2F4120077&amp;rft_id=info%3Apmid%2F24274181&amp;rft.jtitle=Annu.+Rev.+Med.&amp;rft.pages=333-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid23695536-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23695536_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Alonso-Camino V, Sánchez-Martín D, Compte M, Nuñez-Prado N, Diaz RM, Vile R et al. (2013). "CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors". <i>Mol Ther Nucleic Acids</i> <b>2</b>: e93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fmtna.2013.19">10.1038/mtna.2013.19</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23695536">23695536</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=CARbodies%3A+Human+Antibodies+Against+Cell+Surface+Tumor+Antigens+Selected+From+Repertoires+Displayed+on+T+Cell+Chimeric+Antigen+Receptors&amp;rft.au=Alonso-Camino%2C+V&amp;rft.au=Alvarez-Vallina%2C+L&amp;rft.au=Compte%2C+M&amp;rft.au=Diaz%2C+RM&amp;rft.aufirst=V&amp;rft.aulast=Alonso-Camino&amp;rft.au=Nu%C3%B1ez-Prado%2C+N&amp;rft.au=S%C3%A1nchez-Mart%C3%ADn%2C+D&amp;rft.au=Vile%2C+R&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fmtna.2013.19&amp;rft_id=info%3Apmid%2F23695536&amp;rft.jtitle=Mol+Ther+Nucleic+Acids&amp;rft.pages=e93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9811723-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9811723_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC110499">"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery"</a>. <i>J. Virol.</i> <b>72</b> (12): 9873–80. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC110499">110499</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9811723">9811723</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Self-inactivating+lentivirus+vector+for+safe+and+efficient+in+vivo+gene+delivery&amp;rft.aulast=Zufferey+R%2C+Dull+T%2C+Mandel+RJ%2C+Bukovsky+A%2C+Quiroz+D%2C+Naldini+L%2C+Trono+D&amp;rft.au=Zufferey+R%2C+Dull+T%2C+Mandel+RJ%2C+Bukovsky+A%2C+Quiroz+D%2C+Naldini+L%2C+Trono+D&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC110499&amp;rft_id=info%3Apmc%2F110499&amp;rft_id=info%3Apmid%2F9811723&amp;rft.issue=12&amp;rft.jtitle=J.+Virol.&amp;rft.pages=9873-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=72" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Park KD (March 2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3974954">"How do we prepare ourselves for a new paradigm of medicine to advance the treatment of pediatric acute lymphoblastic leukemia?"</a>. <i>Blood Research</i> <b>49</b> (1): 3–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.5045%2Fbr.2014.49.1.3">10.5045/br.2014.49.1.3</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3974954">3974954</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24724058">24724058</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=How+do+we+prepare+ourselves+for+a+new+paradigm+of+medicine+to+advance+the+treatment+of+pediatric+acute+lymphoblastic+leukemia%3F&amp;rft.aulast=Park+KD&amp;rft.au=Park+KD&amp;rft.date=March+2014&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3974954&amp;rft_id=info%3Adoi%2F10.5045%2Fbr.2014.49.1.3&amp;rft_id=info%3Apmc%2F3974954&amp;rft_id=info%3Apmid%2F24724058&amp;rft.issue=1&amp;rft.jtitle=Blood+Research&amp;rft.pages=3-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17170120-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17170120_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M, Vance GH, Cherry AM, Higgins RR, Fielding AK, Foroni L, Paietta E, Tallman MS, Litzow MR, Wiernik PH, Rowe JM, Goldstone AH, Dewald GW (Apr 15, 2007). "Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.". <i>Blood</i> <b>109</b> (8): 3189–3197. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2006-10-051912">10.1182/blood-2006-10-051912</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17170120">17170120</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Karyotype+is+an+independent+prognostic+factor+in+adult+acute+lymphoblastic+leukemia+%28ALL%29%3A+analysis+of+cytogenetic+data+from+patients+treated+on+the+Medical+Research+Council+%28MRC%29+UKALLXII%2FEastern+Cooperative+Oncology+Group+%28ECOG%29+2993+trial.&amp;rft.aulast=Moorman+AV%2C+Harrison+CJ%2C+Buck+GA%2C+Richards+SM%2C+Secker-Walker+LM%2C+Martineau+M%2C+Vance+GH%2C+Cherry+AM%2C+Higgins+RR%2C+Fielding+AK%2C+Foroni+L%2C+Paietta+E%2C+Tallman+MS%2C+Litzow+MR%2C+Wiernik+PH%2C+Rowe+JM%2C+Goldstone+AH%2C+Dewald+GW&amp;rft.au=Moorman+AV%2C+Harrison+CJ%2C+Buck+GA%2C+Richards+SM%2C+Secker-Walker+LM%2C+Martineau+M%2C+Vance+GH%2C+Cherry+AM%2C+Higgins+RR%2C+Fielding+AK%2C+Foroni+L%2C+Paietta+E%2C+Tallman+MS%2C+Litzow+MR%2C+Wiernik+PH%2C+Rowe+JM%2C+Goldstone+AH%2C+Dewald+GW&amp;rft.date=Apr+15%2C+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2006-10-051912&amp;rft_id=info%3Apmid%2F17170120&amp;rft.issue=8&amp;rft.jtitle=Blood&amp;rft.pages=3189-3197&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=109" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17890455-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17890455_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kawamata N, Ogawa S, Zimmermann M, Kato M, Sanada M, Hemminki K, Yamatomo G, Nannya Y, Koehler R, Flohr T, Miller CW, Harbott J, Ludwig WD, Stanulla M, Schrappe M, Bartram CR, Koeffler HP (Jan 15, 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2200831">"Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray."</a>. <i>Blood</i> <b>111</b> (2): 776–784. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2007-05-088310">10.1182/blood-2007-05-088310</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2200831">2200831</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17890455">17890455</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Molecular+allelokaryotyping+of+pediatric+acute+lymphoblastic+leukemias+by+high-resolution+single+nucleotide+polymorphism+oligonucleotide+genomic+microarray.&amp;rft.au=Kawamata+N%2C+Ogawa+S%2C+Zimmermann+M%2C+Kato+M%2C+Sanada+M%2C+Hemminki+K%2C+Yamatomo+G%2C+Nannya+Y%2C+Koehler+R%2C+Flohr+T%2C+Miller+CW%2C+Harbott+J%2C+Ludwig+WD%2C+Stanulla+M%2C+Schrappe+M%2C+Bartram+CR%2C+Koeffler+HP&amp;rft.aulast=Kawamata+N%2C+Ogawa+S%2C+Zimmermann+M%2C+Kato+M%2C+Sanada+M%2C+Hemminki+K%2C+Yamatomo+G%2C+Nannya+Y%2C+Koehler+R%2C+Flohr+T%2C+Miller+CW%2C+Harbott+J%2C+Ludwig+WD%2C+Stanulla+M%2C+Schrappe+M%2C+Bartram+CR%2C+Koeffler+HP&amp;rft.date=Jan+15%2C+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2200831&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-05-088310&amp;rft_id=info%3Apmc%2F2200831&amp;rft_id=info%3Apmid%2F17890455&amp;rft.issue=2&amp;rft.jtitle=Blood&amp;rft.pages=776-784&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=111" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18803328-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18803328_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bungaro S, Dell'Orto MC, Zangrando A, Basso D, Gorletta T, Lo Nigro L, Leszl A, Young BD, Basso G, Bicciato S, Biondi A, te Kronnie G, Cazzaniga G (1 January 2009). "Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks". <i>Genes, Chromosomes and Cancer</i> <b>48</b> (1): 22–38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fgcc.20616">10.1002/gcc.20616</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18803328">18803328</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Integration+of+genomic+and+gene+expression+data+of+childhood+ALL+without+known+aberrations+identifies+subgroups+with+specific+genetic+hallmarks&amp;rft.au=Bungaro+S%2C+Dell%27Orto+MC%2C+Zangrando+A%2C+Basso+D%2C+Gorletta+T%2C+Lo+Nigro+L%2C+Leszl+A%2C+Young+BD%2C+Basso+G%2C+Bicciato+S%2C+Biondi+A%2C+te+Kronnie+G%2C+Cazzaniga+G&amp;rft.aulast=Bungaro+S%2C+Dell%27Orto+MC%2C+Zangrando+A%2C+Basso+D%2C+Gorletta+T%2C+Lo+Nigro+L%2C+Leszl+A%2C+Young+BD%2C+Basso+G%2C+Bicciato+S%2C+Biondi+A%2C+te+Kronnie+G%2C+Cazzaniga+G&amp;rft.date=1+January+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fgcc.20616&amp;rft_id=info%3Apmid%2F18803328&amp;rft.issue=1&amp;rft.jtitle=Genes%2C+Chromosomes+and+Cancer&amp;rft.pages=22-38&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18838613-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18838613_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sulong S, Moorman AV, Irving JA, Strefford JC, Konn ZJ, Case MC, Minto L, Barber KE, Parker H, Wright SL, Stewart AR, Bailey S, Bown NP, Hall AG, Harrison CJ (Jan 1, 2009). "A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups.". <i>Blood</i> <b>113</b> (1): 100–107. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2008-07-166801">10.1182/blood-2008-07-166801</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18838613">18838613</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=A+comprehensive+analysis+of+the+CDKN2A+gene+in+childhood+acute+lymphoblastic+leukemia+reveals+genomic+deletion%2C+copy+number+neutral+loss+of+heterozygosity%2C+and+association+with+specific+cytogenetic+subgroups.&amp;rft.aulast=Sulong+S%2C+Moorman+AV%2C+Irving+JA%2C+Strefford+JC%2C+Konn+ZJ%2C+Case+MC%2C+Minto+L%2C+Barber+KE%2C+Parker+H%2C+Wright+SL%2C+Stewart+AR%2C+Bailey+S%2C+Bown+NP%2C+Hall+AG%2C+Harrison+CJ&amp;rft.au=Sulong+S%2C+Moorman+AV%2C+Irving+JA%2C+Strefford+JC%2C+Konn+ZJ%2C+Case+MC%2C+Minto+L%2C+Barber+KE%2C+Parker+H%2C+Wright+SL%2C+Stewart+AR%2C+Bailey+S%2C+Bown+NP%2C+Hall+AG%2C+Harrison+CJ&amp;rft.date=Jan+1%2C+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2008-07-166801&amp;rft_id=info%3Apmid%2F18838613&amp;rft.issue=1&amp;rft.jtitle=Blood&amp;rft.pages=100-107&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=113" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19138562-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19138562_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, Van Zutven LJ, Beverloo HB, Van der Spek PJ, Escherich G, Horstmann MA, Janka-Schaub GE, Kamps WA, Evans WE, Pieters R (January 2009). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S1470-2045(08)70339-5">"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study"</a>. <i>Lancet Oncol.</i> <b>10</b> (2): 125–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1470-2045%2808%2970339-5">10.1016/S1470-2045(08)70339-5</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2707020">2707020</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19138562">19138562</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=A+subtype+of+childhood+acute+lymphoblastic+leukaemia+with+poor+treatment+outcome%3A+a+genome-wide+classification+study&amp;rft.au=Den+Boer+ML%2C+van+Slegtenhorst+M%2C+De+Menezes+RX%2C+Cheok+MH%2C+Buijs-Gladdines+JG%2C+Peters+ST%2C+Van+Zutven+LJ%2C+Beverloo+HB%2C+Van+der+Spek+PJ%2C+Escherich+G%2C+Horstmann+MA%2C+Janka-Schaub+GE%2C+Kamps+WA%2C+Evans+WE%2C+Pieters+R&amp;rft.aulast=Den+Boer+ML%2C+van+Slegtenhorst+M%2C+De+Menezes+RX%2C+Cheok+MH%2C+Buijs-Gladdines+JG%2C+Peters+ST%2C+Van+Zutven+LJ%2C+Beverloo+HB%2C+Van+der+Spek+PJ%2C+Escherich+G%2C+Horstmann+MA%2C+Janka-Schaub+GE%2C+Kamps+WA%2C+Evans+WE%2C+Pieters+R&amp;rft.date=January+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1470-2045%2808%2970339-5&amp;rft_id=info%3Adoi%2F10.1016%2FS1470-2045%2808%2970339-5&amp;rft_id=info%3Apmc%2F2707020&amp;rft_id=info%3Apmid%2F19138562&amp;rft.issue=2&amp;rft.jtitle=Lancet+Oncol.&amp;rft.pages=125-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ACS_2014_Stats-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-ACS_2014_Stats_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ward E, DeSantis C, Robbins A, Kohler B, Jemal A (Mar–Apr 2014). "Childhood and adolescent cancer statistics, 2014.". <i>CA: a cancer journal for clinicians</i> <b>64</b> (2): 83–103. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3322%2Fcaac.21219">10.3322/caac.21219</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24488779">24488779</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Childhood+and+adolescent+cancer+statistics%2C+2014.&amp;rft.aulast=Ward+E%2C+DeSantis+C%2C+Robbins+A%2C+Kohler+B%2C+Jemal+A&amp;rft.au=Ward+E%2C+DeSantis+C%2C+Robbins+A%2C+Kohler+B%2C+Jemal+A&amp;rft.date=Mar-Apr+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3322%2Fcaac.21219&amp;rft_id=info%3Apmid%2F24488779&amp;rft.issue=2&amp;rft.jtitle=CA%3A+a+cancer+journal+for+clinicians&amp;rft.pages=83-103&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Perillat-Menegaux F, Clavel J, Auclerc MF, Baruchel A, Leverger G, Nelken B, Philippe N, Sommelet D, Vilmer E, Hémon D (2003). <a rel="nofollow" class="external text" href="http://cebp.aacrjournals.org/content/12/1/60.long">"Family History of Autoimmune Thyroid Disease and Childhood Acute Leukemia"</a>. <i>Cancer Epidemiology, Biomarkers &amp; Prevention</i> <b>12</b> (1): 60–3. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12540505">12540505</a><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2014</span>. <q>A statistically significant association between a history of autoimmune disease in first- or second-degree relatives and ALL (OR, 1.7; 95% confidence interval (CI), 1.0–2.8) was found. A relationship between thyroid diseases overall and ALL...was observed. This association was more pronounced for potentially autoimmune thyroid diseases (Grave’s disease and/or hyperthyroidism and Hashimoto’s disease and/or hypothyroidism) (OR, 3.5; 95% CI, 1.1–10.7 and OR, 5.6; 95% CI, 1.0–31.1, respectively for ALL and ANLL), whereas it was not statistically significant for the other thyroid diseases...The results suggest that a familial history of autoimmune thyroid disease may be associated with childhood acute leukemia.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Family+History+of+Autoimmune+Thyroid+Disease+and+Childhood+Acute+Leukemia&amp;rft.aulast=Perillat-Menegaux+F%2C+Clavel+J%2C+Auclerc+MF%2C+Baruchel+A%2C+Leverger+G%2C+Nelken+B%2C+Philippe+N%2C+Sommelet+D%2C+Vilmer+E%2C+H%C3%A9mon+D&amp;rft.au=Perillat-Menegaux+F%2C+Clavel+J%2C+Auclerc+MF%2C+Baruchel+A%2C+Leverger+G%2C+Nelken+B%2C+Philippe+N%2C+Sommelet+D%2C+Vilmer+E%2C+H%C3%A9mon+D&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcebp.aacrjournals.org%2Fcontent%2F12%2F1%2F60.long&amp;rft_id=info%3Apmid%2F12540505&amp;rft.issue=1&amp;rft.jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&amp;rft.pages=60-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancerresearchuk.org/cancer-info/cancerstats/types/Leukaemia-ALL/">"Acute lymphoblastic leukaemia (ALL) statistics"</a>. <i>Cancer Research UK</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Acute+lymphoblastic+leukaemia+%28ALL%29+statistics&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fcancer-info%2Fcancerstats%2Ftypes%2FLeukaemia-ALL%2F&amp;rft.jtitle=Cancer+Research+UK&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Shapira-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-Shapira_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shapira_38-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Shapira T, Pereg D, Lishner M (September 2008). "How I treat acute and chronic leukemia in pregnancy". <i>Blood Rev.</i> <b>22</b> (5): 247–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.blre.2008.03.006">10.1016/j.blre.2008.03.006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18472198">18472198</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=How+I+treat+acute+and+chronic+leukemia+in+pregnancy&amp;rft.aulast=Shapira+T%2C+Pereg+D%2C+Lishner+M&amp;rft.au=Shapira+T%2C+Pereg+D%2C+Lishner+M&amp;rft.date=September+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.blre.2008.03.006&amp;rft_id=info%3Apmid%2F18472198&amp;rft.issue=5&amp;rft.jtitle=Blood+Rev.&amp;rft.pages=247-59&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation journal">Isoda T, Ford AM, Tomizawa D, van Delft FW, De Castro DG, Mitsuiki N, Score J, Taki T, Morio T, Takagi M, Saji H, Greaves M, Mizutani S (October 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2764945">"Immunologically silent cancer clone transmission from mother to offspring"</a>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>106</b> (42): 17882–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.0904658106">10.1073/pnas.0904658106</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2764945">2764945</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19822752">19822752</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcute+lymphoblastic+leukemia&amp;rft.atitle=Immunologically+silent+cancer+clone+transmission+from+mother+to+offspring&amp;rft.au=Isoda+T%2C+Ford+AM%2C+Tomizawa+D%2C+van+Delft+FW%2C+De+Castro+DG%2C+Mitsuiki+N%2C+Score+J%2C+Taki+T%2C+Morio+T%2C+Takagi+M%2C+Saji+H%2C+Greaves+M%2C+Mizutani+S&amp;rft.aulast=Isoda+T%2C+Ford+AM%2C+Tomizawa+D%2C+van+Delft+FW%2C+De+Castro+DG%2C+Mitsuiki+N%2C+Score+J%2C+Taki+T%2C+Morio+T%2C+Takagi+M%2C+Saji+H%2C+Greaves+M%2C+Mizutani+S&amp;rft.date=October+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2764945&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0904658106&amp;rft_id=info%3Apmc%2F2764945&amp;rft_id=info%3Apmid%2F19822752&amp;rft.issue=42&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.pages=17882-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=106" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit&amp;section=21" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="https://www.dmoz.org/Health/Conditions_and_Diseases/Cancer/Hematologic/Leukemia/Acute_Lymphocytic/">Acute lymphoblastic leukemia</a> at <a href="/wiki/DMOZ" title="DMOZ">DMOZ</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=57">Acute Lymphocytic Leukemia</a> at <a href="/wiki/American_Cancer_Society" title="American Cancer Society">American Cancer Society</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymphoid_malignancy" title="Template talk:Lymphoid malignancy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymphoid_malignancy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues" title="Tumors of the hematopoietic and lymphoid tissues">Hematological malignancy</a>/<a href="/wiki/Leukemia" title="Leukemia">leukemia</a> histology (<a href="/wiki/International_Classification_of_Diseases_for_Oncology#.289590.E2.80.939999.29_Hematologic_.28Leukemias.2C_Lymphomas_and_related_disorders.29" title="International Classification of Diseases for Oncology">ICD-O 9590–9989</a>, <a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C81.E2.80.93C96.29_Malignant_neoplasms.2C_stated_or_presumed_to_be_primary.2C_of_lymphoid.2C_haematopoietic_and_related_tissue" title="ICD-10 Chapter II: Neoplasms">C81–C96</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_lymphatic_and_hematopoietic_tissue_.28200.E2.80.93208.29" title="List of ICD-9 codes 140–239: neoplasms">200–208</a>)<br />
<a href="/wiki/Lymphocyte" title="Lymphocyte">Lymphoid</a>/<a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative</a>, <a href="/wiki/Lymphoma" title="Lymphoma">Lymphomas</a>/<a href="/wiki/Lymphoid_leukemia" title="Lymphoid leukemia">Lymphoid leukemias</a> (9590–9739, 9800–9839)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_B_cell_neoplasms" title="Lymphoma">B cell</a><br />
(<a href="/wiki/B-cell_lymphoma" title="B-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/B-cell_leukemia" title="B-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD19" title="CD19">CD19</a>
<ul>
<li><a href="/wiki/CD20" title="CD20">CD20</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">ALL</strong> (<a href="/wiki/Precursor_B-cell_lymphoblastic_leukemia" title="Precursor B-cell lymphoblastic leukemia">Precursor B acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD5_(protein)" title="CD5 (protein)">CD5</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Naive_B_cell" title="Naive B cell">naive B cell</a></i> (<a href="/wiki/B-cell_chronic_lymphocytic_leukemia" title="B-cell chronic lymphocytic leukemia">CLL/SLL</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Mantle_zone" title="Mantle zone">mantle zone</a></i> (<a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD22" title="CD22">CD22</a>+</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/B-cell_prolymphocytic_leukemia" title="B-cell prolymphocytic leukemia">Prolymphocytic</a></li>
<li><i><a href="/wiki/CD11c" title="CD11c">CD11c+</a></i> (<a href="/wiki/Hairy_cell_leukemia" title="Hairy cell leukemia">Hairy cell leukemia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD79A" title="CD79A">CD79a</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Germinal_center" title="Germinal center">germinal center</a>/<a href="/wiki/Follicular_B_cell" title="Follicular B cell">follicular B cell</a></i> (<a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular</a></li>
<li><a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's</a></li>
<li><a href="/wiki/GCB_DLBCL" title="GCB DLBCL" class="mw-redirect">GCB DLBCL</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Marginal_zone_B-cell_lymphoma" title="Marginal zone B-cell lymphoma">marginal zone</a>/<a href="/wiki/Marginal-zone_B_cell" title="Marginal-zone B cell" class="mw-redirect">marginal-zone B cell</a></i> (<a href="/wiki/Splenic_marginal_zone_lymphoma" title="Splenic marginal zone lymphoma">Splenic marginal zone</a></li>
<li><a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT</a></li>
<li><a href="/wiki/Nodal_marginal_zone_B_cell_lymphoma" title="Nodal marginal zone B cell lymphoma">Nodal marginal zone</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Reed-Sternberg_cell" title="Reed-Sternberg cell" class="mw-redirect">RS</a> (<a href="/wiki/CD15" title="CD15">CD15</a>+, <a href="/wiki/CD30" title="CD30">CD30</a>+)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma">Classic Hodgkin's lymphoma</a> (<a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">Nodular sclerosis</a>)</li>
<li><i><a href="/wiki/CD20" title="CD20">CD20+</a></i> (<a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin%27s_lymphoma" title="Nodular lymphocyte predominant Hodgkin's lymphoma">Nodular lymphocyte predominant Hodgkin's lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Plasma_cell_dyscrasia" title="Plasma cell dyscrasia">PCDs</a>/<a href="/wiki/Paraproteinemia" title="Paraproteinemia">PP</a><br />
(<a href="/wiki/CD38" title="CD38">CD38</a>+/<a href="/wiki/CD138" title="CD138" class="mw-redirect">CD138</a>+)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>see <a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">immunoproliferative immunoglobulin disorders</a></i></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Kaposi%27s_sarcoma-associated_herpesvirus" title="Kaposi's sarcoma-associated herpesvirus">KSHV</a></i> (<a href="/wiki/Primary_effusion_lymphoma" title="Primary effusion lymphoma">Primary effusion</a>)</li>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Lymphomatoid_granulomatosis" title="Lymphomatoid granulomatosis">Lymphomatoid granulomatosis</a></li>
<li><a href="/wiki/Post-transplant_lymphoproliferative_disorder" title="Post-transplant lymphoproliferative disorder">Post-transplant lymphoproliferative disorder</a>)</li>
<li><i><a href="/wiki/HIV" title="HIV">HIV</a></i> (<a href="/wiki/AIDS-related_lymphoma" title="AIDS-related lymphoma">AIDS-related lymphoma</a>)</li>
<li><i><a href="/wiki/Helicobacter_pylori" title="Helicobacter pylori">Helicobacter pylori</a></i> (<a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_B-cell_lymphoma" title="Cutaneous B-cell lymphoma">Cutaneous</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diffuse_large_B-cell_lymphoma" title="Diffuse large B-cell lymphoma">Diffuse large B-cell lymphoma</a></li>
<li><a href="/wiki/Intravascular_large_B-cell_lymphoma" title="Intravascular large B-cell lymphoma">Intravascular large B-cell lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_immunocytoma" title="Primary cutaneous immunocytoma">Primary cutaneous immunocytoma</a></li>
<li><a href="/wiki/Plasmacytoma" title="Plasmacytoma">Plasmacytoma</a></li>
<li><a href="/wiki/Plasmacytosis" title="Plasmacytosis">Plasmacytosis</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">T/NK</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/T_cell" title="T cell">T cell</a><br />
(<a href="/wiki/T-cell_lymphoma" title="T-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/T-cell_leukemia" title="T-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a>
<ul>
<li><a href="/wiki/CD4" title="CD4">CD4</a></li>
<li><a href="/wiki/CD8" title="CD8">CD8</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a>: <strong class="selflink">ALL</strong> (<a href="/wiki/Precursor_T-cell_lymphoblastic_leukemia" title="Precursor T-cell lymphoblastic leukemia" class="mw-redirect">Precursor T acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Prolymphocyte" title="Prolymphocyte">prolymphocyte</a></i> (<a href="/wiki/T-cell_prolymphocytic_leukemia" title="T-cell prolymphocytic leukemia">Prolymphocytic</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/CD30" title="CD30">CD30+</a></i> (<a href="/wiki/Anaplastic_large-cell_lymphoma" title="Anaplastic large-cell lymphoma">Anaplastic large-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_T-cell_lymphoma" title="Cutaneous T-cell lymphoma" class="mw-redirect">Cutaneous</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">MF+variants</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>indolent:</i> <a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">Mycosis fungoides</a></li>
<li><a href="/wiki/Pagetoid_reticulosis" title="Pagetoid reticulosis">Pagetoid reticulosis</a></li>
<li><a href="/wiki/Granulomatous_slack_skin" title="Granulomatous slack skin">Granulomatous slack skin</a></li>
</ul>
<p><i>aggressive:</i> <a href="/wiki/S%C3%A9zary_disease" title="Sézary disease">Sézary disease</a></p>
<ul>
<li><a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Non-MF</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>-: <a href="/wiki/Non-mycosis_fungoides_CD30%E2%88%92_cutaneous_large_T-cell_lymphoma" title="Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma">Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma</a></li>
<li><a href="/wiki/Pleomorphic_T-cell_lymphoma" title="Pleomorphic T-cell lymphoma">Pleomorphic T-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type B</a></li>
</ul>
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>+: <a href="/wiki/CD30%2B_cutaneous_T-cell_lymphoma" title="CD30+ cutaneous T-cell lymphoma">CD30+ cutaneous T-cell lymphoma</a></li>
<li><a href="/wiki/Secondary_cutaneous_CD30%2B_large_cell_lymphoma" title="Secondary cutaneous CD30+ large cell lymphoma" class="mw-redirect">Secondary cutaneous CD30+ large cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other <a href="/wiki/Peripheral_T-cell_lymphoma" title="Peripheral T-cell lymphoma">peripheral</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hepatosplenic_T-cell_lymphoma" title="Hepatosplenic T-cell lymphoma">Hepatosplenic</a></li>
<li><a href="/wiki/Angioimmunoblastic_T-cell_lymphoma" title="Angioimmunoblastic T-cell lymphoma">Angioimmunoblastic</a></li>
<li><a href="/wiki/Enteropathy-associated_T-cell_lymphoma" title="Enteropathy-associated T-cell lymphoma">Enteropathy-associated T-cell lymphoma</a></li>
<li><a href="/wiki/Peripheral_T-cell_lymphoma-Not-Otherwise-Specified" title="Peripheral T-cell lymphoma-Not-Otherwise-Specified" class="mw-redirect">Peripheral T-cell lymphoma-Not-Otherwise-Specified</a> (<a href="/wiki/Lennert_lymphoma" title="Lennert lymphoma">Lennert lymphoma</a>)</li>
<li><a href="/wiki/Subcutaneous_T-cell_lymphoma" title="Subcutaneous T-cell lymphoma">Subcutaneous T-cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Human_T-lymphotropic_virus_1" title="Human T-lymphotropic virus 1">HTLV-1</a></i> (<a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">NK cell</a>/<br />
(most <a href="/wiki/CD56" title="CD56" class="mw-redirect">CD56</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Aggressive_NK-cell_leukemia" title="Aggressive NK-cell leukemia">Aggressive NK-cell leukemia</a></li>
<li><a href="/wiki/Blastic_NK_cell_lymphoma" title="Blastic NK cell lymphoma">Blastic NK cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">T or NK</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Extranodal_NK-T-cell_lymphoma" title="Extranodal NK-T-cell lymphoma" class="mw-redirect">Extranodal NK-T-cell lymphoma</a>/<a href="/wiki/Angiocentric_lymphoma" title="Angiocentric lymphoma" class="mw-redirect">Angiocentric lymphoma</a>)</li>
<li><a href="/wiki/Large_granular_lymphocytic_leukemia" title="Large granular lymphocytic leukemia">Large granular lymphocytic leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Lymphoid+myeloid</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_biphenotypic_leukaemia" title="Acute biphenotypic leukaemia">Acute biphenotypic leukaemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphocytosis" title="Lymphocytosis">Lymphocytosis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative disorders</a> (<a href="/wiki/X-linked_lymphoproliferative_disease" title="X-linked lymphoproliferative disease">X-linked lymphoproliferative disease</a></li>
<li><a href="/wiki/Autoimmune_lymphoproliferative_syndrome" title="Autoimmune lymphoproliferative syndrome">Autoimmune lymphoproliferative syndrome</a>)</li>
<li><a href="/wiki/Leukemoid_reaction" title="Leukemoid reaction">Leukemoid reaction</a></li>
<li><a href="/wiki/Diffuse_infiltrative_lymphocytosis_syndrome" title="Diffuse infiltrative lymphocytosis syndrome">Diffuse infiltrative lymphocytosis syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a>
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_bandlike_and_perivascular_patterns" title="Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns" class="mw-redirect">with bandlike and perivascular patterns</a></li>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_nodular_pattern" title="Cutaneous lymphoid hyperplasia with nodular pattern" class="mw-redirect">with nodular pattern</a></li>
</ul>
</li>
<li><a href="/wiki/Jessner_lymphocytic_infiltrate_of_the_skin" title="Jessner lymphocytic infiltrate of the skin" class="mw-redirect">Jessner lymphocytic infiltrate of the skin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymph_immune_and_complement_navs" title="Template:Lymph immune and complement navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymph_immune_and_complement_navs" title="Template talk:Lymph immune and complement navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymph_immune_and_complement_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Immune_system" title="Immune system">immune system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Lymphocytic_immune_system" title="Template:Lymphocytic immune system">Physiology</a>
<ul>
<li><a href="/wiki/Template:Lymphocytes" title="Template:Lymphocytes">cells</a></li>
<li><a href="/wiki/Template:Autoantigens" title="Template:Autoantigens">autoantigens</a></li>
<li><a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies">autoantibodies</a></li>
<li><a href="/wiki/Template:Complement_system" title="Template:Complement system">complement</a></li>
<li><a href="/wiki/Template:Surface_antigens" title="Template:Surface antigens">surface antigens</a></li>
<li><a href="/wiki/Template:Immunoglobulin_superfamily_immune_receptors" title="Template:Immunoglobulin superfamily immune receptors">IG receptors</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Allergic_conditions" title="Template:Allergic conditions">Allergies</a></li>
<li><a href="/wiki/Template:Lymphoid_and_complement_immunodeficiency" title="Template:Lymphoid and complement immunodeficiency">Immunodeficiency</a></li>
<li><a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">Immunoproliferative immunoglobulin disorders</a></li>
<li><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases">Hypersensitivity and autoimmune disorders</a></li>
<li><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy">Neoplasms and cancer</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Immunologic_techniques_and_tests" title="Template:Immunologic techniques and tests">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antihistamines" title="Template:Antihistamines">antihistamines</a></li>
<li><a href="/wiki/Template:Immunostimulants" title="Template:Immunostimulants">immunostimulants</a></li>
<li><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants">immunosuppressants</a></li>
<li><a href="/wiki/Template:Monoclonals_for_immune_system" title="Template:Monoclonals for immune system">monoclonal antibodies</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Chromosomal_abnormalities" title="Template:Chromosomal abnormalities"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Chromosomal_abnormalities" title="Template talk:Chromosomal abnormalities"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Chromosomal_abnormalities&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Chromosome_abnormality" title="Chromosome abnormality">Chromosome abnormalities</a> (<a href="/wiki/ICD-10_Chapter_Q#Q90.E2.80.93Q99_.E2.80.93_Chromosomal_abnormalities.2C_not_elsewhere_classified" title="ICD-10 Chapter Q" class="mw-redirect">Q90–Q99</a>, <a href="/wiki/List_of_ICD-9_codes_740%E2%80%93759:_congenital_anomalies#Chromosomal_anomalies" title="List of ICD-9 codes 740–759: congenital anomalies">758</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Autosome" title="Autosome">Autosomal</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Trisomy" title="Trisomy">Trisomies</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Down_syndrome" title="Down syndrome">Down syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_21_(human)" title="Chromosome 21 (human)">21</a></li>
</ul>
</li>
<li><a href="/wiki/Edwards_syndrome" title="Edwards syndrome">Edwards syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_18_(human)" title="Chromosome 18 (human)">18</a></li>
</ul>
</li>
<li><a href="/wiki/Patau_syndrome" title="Patau syndrome">Patau syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_13_(human)" title="Chromosome 13 (human)">13</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Trisomy_9" title="Trisomy 9">Trisomy 9</a></li>
<li><a href="/wiki/Warkany_syndrome_2" title="Warkany syndrome 2" class="mw-redirect">Warkany syndrome 2</a>
<ul>
<li><a href="/wiki/Chromosome_8_(human)" title="Chromosome 8 (human)">8</a></li>
</ul>
</li>
<li><a href="/wiki/Cat_eye_syndrome" title="Cat eye syndrome">Cat eye syndrome</a>/<a href="/wiki/Trisomy_22" title="Trisomy 22">Trisomy 22</a>
<ul>
<li><a href="/wiki/Chromosome_22_(human)" title="Chromosome 22 (human)">22</a></li>
</ul>
</li>
<li><a href="/wiki/Trisomy_16" title="Trisomy 16">Trisomy 16</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Monosomy" title="Monosomy">Monosomies</a>/<a href="/wiki/Deletion_(genetics)" title="Deletion (genetics)">deletions</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/1q21.1_deletion_syndrome" title="1q21.1 deletion syndrome">1q21.1 deletion syndrome</a>/<a href="/wiki/1q21.1_duplication_syndrome" title="1q21.1 duplication syndrome">1q21.1 duplication syndrome</a>/<a href="/wiki/TAR_syndrome" title="TAR syndrome">TAR syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_1_(human)" title="Chromosome 1 (human)">1</a></li>
</ul>
</li>
<li><a href="/wiki/Wolf%E2%80%93Hirschhorn_syndrome" title="Wolf–Hirschhorn syndrome">Wolf–Hirschhorn syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_4_(human)" title="Chromosome 4 (human)">4</a></li>
</ul>
</li>
<li><a href="/wiki/Cri_du_chat" title="Cri du chat">Cri du chat</a>/<a href="/wiki/Chromosome_5q_deletion_syndrome" title="Chromosome 5q deletion syndrome">Chromosome 5q deletion syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_5_(human)" title="Chromosome 5 (human)">5</a></li>
</ul>
</li>
<li><a href="/wiki/Williams_syndrome" title="Williams syndrome">Williams syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_7_(human)" title="Chromosome 7 (human)">7</a></li>
</ul>
</li>
<li><a href="/wiki/Jacobsen_syndrome" title="Jacobsen syndrome">Jacobsen syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_11_(human)" title="Chromosome 11 (human)">11</a></li>
</ul>
</li>
<li><a href="/wiki/Miller%E2%80%93Dieker_syndrome" title="Miller–Dieker syndrome">Miller–Dieker syndrome</a>/<a href="/wiki/Smith%E2%80%93Magenis_syndrome" title="Smith–Magenis syndrome">Smith–Magenis syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_17_(human)" title="Chromosome 17 (human)">17</a></li>
</ul>
</li>
<li><a href="/wiki/DiGeorge_syndrome" title="DiGeorge syndrome">DiGeorge syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_22_(human)" title="Chromosome 22 (human)">22</a></li>
</ul>
</li>
<li><a href="/wiki/22q11.2_distal_deletion_syndrome" title="22q11.2 distal deletion syndrome">22q11.2 distal deletion syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_22_(human)" title="Chromosome 22 (human)">22</a></li>
</ul>
</li>
<li><a href="/wiki/22q13_deletion_syndrome" title="22q13 deletion syndrome">22q13 deletion syndrome</a>
<ul>
<li><a href="/wiki/Chromosome_22_(human)" title="Chromosome 22 (human)">22</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Genomic_imprinting" title="Genomic imprinting">genomic imprinting</a></i>
<ul>
<li><a href="/wiki/Angelman_syndrome" title="Angelman syndrome">Angelman syndrome</a>/<a href="/wiki/Prader%E2%80%93Willi_syndrome" title="Prader–Willi syndrome">Prader–Willi syndrome</a> (<a href="/wiki/Chromosome_15_(human)" title="Chromosome 15 (human)">15</a>)</li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Distal_18q-" title="Distal 18q-">Distal 18q-</a>/<a href="/wiki/Proximal_18q-" title="Proximal 18q-">Proximal 18q-</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/X_chromosome" title="X chromosome">X</a>/<a href="/wiki/Y_chromosome" title="Y chromosome">Y</a> linked</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Monosomy" title="Monosomy">Monosomy</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Turner_syndrome" title="Turner syndrome">Turner syndrome (45,X)</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Trisomy" title="Trisomy">Trisomy</a>/<a href="/wiki/Tetrasomy" title="Tetrasomy">tetrasomy</a>,<br />
<a href="/wiki/Aneuploidy" title="Aneuploidy">other karyotypes</a>/<a href="/wiki/Mosaic_(genetics)" title="Mosaic (genetics)">mosaics</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Klinefelter_syndrome" title="Klinefelter syndrome">Klinefelter syndrome (47,XXY)</a></li>
<li><a href="/wiki/XXYY_syndrome" title="XXYY syndrome">48,XXYY</a></li>
<li><a href="/wiki/48,_XXXY" title="48, XXXY" class="mw-redirect">48,XXXY</a></li>
<li><a href="/w/index.php?title=49,_XXXYY&amp;action=edit&amp;redlink=1" class="new" title="49, XXXYY (page does not exist)">49,XXXYY</a></li>
<li><a href="/wiki/49,_XXXXY_syndrome" title="49, XXXXY syndrome">49,XXXXY</a></li>
</ul>
<ul>
<li><a href="/wiki/Triple_X_syndrome" title="Triple X syndrome">Triple X syndrome (47,XXX)</a></li>
<li><a href="/wiki/48,_XXXX" title="48, XXXX">48,XXXX</a></li>
<li><a href="/wiki/49,_XXXXX" title="49, XXXXX">49,XXXXX</a></li>
</ul>
<ul>
<li><a href="/wiki/XYY_syndrome" title="XYY syndrome">47,XYY</a></li>
<li><a href="/w/index.php?title=48,_XYYY&amp;action=edit&amp;redlink=1" class="new" title="48, XYYY (page does not exist)">48,XYYY</a></li>
<li><a href="/w/index.php?title=49,_XYYYY&amp;action=edit&amp;redlink=1" class="new" title="49, XYYYY (page does not exist)">49,XYYYY</a></li>
</ul>
<ul>
<li><a href="/wiki/46,_XX/XY" title="46, XX/XY">46,XX/XY</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Chromosomal_translocation" title="Chromosomal translocation">Translocations</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Leukemia" title="Leukemia">Leukemia</a>/<a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Lymphoid</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's lymphoma</a> t(8 <a href="/wiki/Myc" title="Myc">MYC</a>;14 <a href="/wiki/IGH@" title="IGH@">IGH</a>)</li>
<li><a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular lymphoma</a> t(14 <a href="/wiki/IGH@" title="IGH@">IGH</a>;18 <a href="/wiki/Bcl-2" title="Bcl-2">BCL2</a>)</li>
<li><a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell lymphoma</a>/<a href="/wiki/Multiple_myeloma" title="Multiple myeloma">Multiple myeloma</a> t(11 <a href="/wiki/Cyclin_D1" title="Cyclin D1">CCND1</a>:14 <a href="/wiki/IGH@" title="IGH@">IGH</a>)</li>
<li><a href="/wiki/Anaplastic_large_cell_lymphoma" title="Anaplastic large cell lymphoma" class="mw-redirect">Anaplastic large cell lymphoma</a> t(2 <a href="/wiki/Anaplastic_lymphoma_kinase" title="Anaplastic lymphoma kinase">ALK</a>;5 <a href="/wiki/NPM1" title="NPM1">NPM1</a>)</li>
<li><strong class="selflink">Acute lymphoblastic leukemia</strong></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Myeloid</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a> t(9 <a href="/wiki/Abl_gene" title="Abl gene" class="mw-redirect">ABL</a>; 22 <a href="/wiki/BCR_gene" title="BCR gene" class="mw-redirect">BCR</a>)</li>
<li><a href="/wiki/Acute_myeloblastic_leukemia_with_maturation" title="Acute myeloblastic leukemia with maturation">Acute myeloblastic leukemia with maturation</a> t(8 <a href="/wiki/RUNX1T1" title="RUNX1T1">RUNX1T1</a>;21 <a href="/wiki/RUNX1" title="RUNX1">RUNX1</a>)</li>
<li><a href="/wiki/Acute_promyelocytic_leukemia" title="Acute promyelocytic leukemia">Acute promyelocytic leukemia</a> t(15 <a href="/wiki/Promyelocytic_leukemia_protein" title="Promyelocytic leukemia protein">PML</a>,17 <a href="/wiki/Retinoic_acid_receptor_alpha" title="Retinoic acid receptor alpha">RARA</a>)</li>
<li><a href="/wiki/Acute_megakaryoblastic_leukemia" title="Acute megakaryoblastic leukemia">Acute megakaryoblastic leukemia</a> t(1 <a href="/wiki/RBM15" title="RBM15">RBM15</a>;22 <a href="/wiki/MKL1" title="MKL1">MKL1</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a> t(11 <a href="/wiki/FLI1" title="FLI1">FLI1</a>; 22 <a href="/wiki/Ewing_sarcoma_breakpoint_region_1" title="Ewing sarcoma breakpoint region 1">EWS</a>)</li>
<li><a href="/wiki/Synovial_sarcoma" title="Synovial sarcoma">Synovial sarcoma</a> t(x <a href="/wiki/SYT" title="SYT" class="mw-redirect">SYT</a>;18 <a href="/wiki/Synovial_sarcoma,_X_breakpoint" title="Synovial sarcoma, X breakpoint">SSX</a>)</li>
<li><a href="/wiki/Dermatofibrosarcoma_protuberans" title="Dermatofibrosarcoma protuberans">Dermatofibrosarcoma protuberans</a> t(17 <a href="/wiki/Collagen,_type_I,_alpha_1" title="Collagen, type I, alpha 1">COL1A1</a>;22 <a href="/wiki/PDGFB" title="PDGFB">PDGFB</a>)</li>
<li><a href="/wiki/Myxoid_liposarcoma" title="Myxoid liposarcoma">Myxoid liposarcoma</a> t(12 <a href="/wiki/DNA_damage-inducible_transcript_3" title="DNA damage-inducible transcript 3">DDIT3</a>; 16 <a href="/wiki/FUS" title="FUS">FUS</a>)</li>
<li><a href="/wiki/Desmoplastic_small_round_cell_tumor" title="Desmoplastic small round cell tumor" class="mw-redirect">Desmoplastic small round cell tumor</a> t(11 <a href="/wiki/WT1" title="WT1">WT1</a>; 22 <a href="/wiki/Ewing_sarcoma_breakpoint_region_1" title="Ewing sarcoma breakpoint region 1">EWS</a>)</li>
<li><a href="/wiki/Alveolar_rhabdomyosarcoma" title="Alveolar rhabdomyosarcoma">Alveolar rhabdomyosarcoma</a> t(2 <a href="/wiki/PAX3" title="PAX3">PAX3</a>; 13 <a href="/wiki/FOXO1" title="FOXO1">FOXO1</a>) t (1 <a href="/wiki/PAX7" title="PAX7">PAX7</a>; 13 <a href="/wiki/FOXO1" title="FOXO1">FOXO1</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Fragile_X_syndrome" title="Fragile X syndrome">Fragile X syndrome</a></li>
<li><a href="/wiki/Uniparental_disomy" title="Uniparental disomy">Uniparental disomy</a></li>
<li><a href="/wiki/XX_male_syndrome" title="XX male syndrome">XX male syndrome</a></li>
<li><a href="/wiki/Ring_chromosome" title="Ring chromosome">Ring chromosome</a> (13; <a href="/wiki/Ring_chromosome_14_syndrome" title="Ring chromosome 14 syndrome">14</a>; 15; <a href="/wiki/Ring_chromosome_20_syndrome" title="Ring chromosome 20 syndrome">20</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="text-align:center;">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Congenital_disease_navs" title="Template:Congenital disease navs"><span title="View this template" style="text-align:center;;;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Congenital_disease_navs" title="Template talk:Congenital disease navs" class="mw-redirect"><span title="Discuss this template" style="text-align:center;;;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Congenital_disease_navs&amp;action=edit"><span title="Edit this template" style="text-align:center;;;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Embryology" title="Embryology">developmental</a> medicine</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align:center;">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Embryology
<ul>
<li><a href="/wiki/Template:Embryology" title="Template:Embryology">foetus</a></li>
<li><a href="/wiki/Template:Extraembryonic_and_fetal_membranes" title="Template:Extraembryonic and fetal membranes">membranes</a></li>
</ul>
</li>
<li>Cell lines
<ul>
<li><a href="/wiki/Template:Human_cell_types_derived_primarily_from_endoderm" title="Template:Human cell types derived primarily from endoderm">endoderm</a></li>
<li><a href="/wiki/Template:Human_cell_types_derived_primarily_from_mesoderm" title="Template:Human cell types derived primarily from mesoderm">mesoderm</a></li>
<li><a href="/wiki/Template:Human_cell_types_derived_primarily_from_ectoderm" title="Template:Human cell types derived primarily from ectoderm">ectoderm</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align:center;">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Congenital_malformation_due_to_exogenous_toxicity" title="Template:Congenital malformation due to exogenous toxicity">Due to toxins</a></li>
<li><a href="/wiki/Template:Multiple_abnormalities" title="Template:Multiple abnormalities">Syndromes</a></li>
<li><a href="/wiki/Template:Chromosomal_abnormalities" title="Template:Chromosomal abnormalities">Chromosomal</a></li>
<li><a href="/wiki/Template:Pediatric_conditions_originating_in_the_perinatal_period" title="Template:Pediatric conditions originating in the perinatal period">Neonate</a></li>
<li><a href="/wiki/Template:Twin_conditions" title="Template:Twin conditions">Twins</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Arthritis_in_children" title="Template:Arthritis in children"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Arthritis_in_children" title="Template talk:Arthritis in children"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Arthritis_in_children&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Childhood_arthritis" title="Childhood arthritis">Arthritis in children</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Inflammation" title="Inflammation">Inflammatory</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Idiopathic</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">Juvenile idiopathic arthritis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Inflammatory disease</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">Inflammatory bowel disease</a></li>
<li><a href="/wiki/Sarcoidosis" title="Sarcoidosis">Sarcoidosis</a></li>
<li><a href="/wiki/Cystic_fibrosis" title="Cystic fibrosis">Cystic fibrosis</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues" title="Tumors of the hematopoietic and lymphoid tissues">Hematological malignancy</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Acute lymphoblastic leukemia</strong></li>
<li><a href="/wiki/Lymphoma" title="Lymphoma">Lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cancer" title="Cancer">Malignancy</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Neuroblastoma" title="Neuroblastoma">Neuroblastoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>post-streptococcal</li>
<li><a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></li>
<li>postenteric, post-viral</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Septic_arthritis" title="Septic arthritis">Septic arthritis</a></li>
<li><a href="/wiki/Osteomyelitis" title="Osteomyelitis">Osteomyelitis</a></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis</a></li>
<li><a href="/wiki/Lyme_disease#Late_disseminated_infection" title="Lyme disease">Lyme arthritis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Mechanical</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Osgood%E2%80%93Schlatter_disease" title="Osgood–Schlatter disease">Osgood–Schlatter disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Tumours of cartilage bone or muscle</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Benign</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Osteoid_osteoma" title="Osteoid osteoma">Osteoid osteoma</a></li>
<li><a href="/wiki/Pigmented_villonodular_synovitis" title="Pigmented villonodular synovitis">Pigmented villonodular synovitis</a></li>
<li><a href="/wiki/Hemangioma" title="Hemangioma">Hemangioma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Malignant</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Synovial_sarcoma" title="Synovial sarcoma">Synovial sarcoma</a></li>
<li><a href="/wiki/Rhabdomyosarcoma" title="Rhabdomyosarcoma">Rhabdomyosarcoma</a></li>
<li><a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Central Nervous System</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dd>Idiopathic pain syndromes</dd>
<dt>Local</dt>
<dd><a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">Complex regional pain syndrome</a>/Reflex sympathetic dystrophy</dd>
<dt>Generalized</dt>
<dd><a href="/wiki/Fibromyalgia" title="Fibromyalgia">Fibromyalgia</a></dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Joint_navs" title="Template:Joint navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Joint_navs" title="Template talk:Joint navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Joint_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Joint" title="Joint">joint</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Joints" title="Template:Joints">Anatomy</a>
<ul>
<li><a href="/wiki/Template:Joints_of_head_and_neck" title="Template:Joints of head and neck">head and neck</a></li>
<li><a href="/wiki/Template:Cranial_fibrous_joints" title="Template:Cranial fibrous joints">cranial</a></li>
<li><a href="/wiki/Template:Joints_of_upper_limbs" title="Template:Joints of upper limbs">arms</a></li>
<li><a href="/wiki/Template:Joints_of_torso_and_pelvis" title="Template:Joints of torso and pelvis">torso and pelvis</a></li>
<li><a href="/wiki/Template:Joints_of_lower_limbs" title="Template:Joints of lower limbs">legs</a></li>
<li><a href="/wiki/Template:Bursae_and_sheaths" title="Template:Bursae and sheaths">bursae and sheathes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Bone_and_cartilage_physiology" title="Template:Bone and cartilage physiology">Physiology</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Arthropathies_and_related_conditions" title="Template:Arthropathies and related conditions">Arthritis</a>
<ul>
<li><a href="/wiki/Template:Acquired_musculoskeletal_deformities" title="Template:Acquired musculoskeletal deformities">acquired</a></li>
<li><a href="/wiki/Template:Spinal_disease" title="Template:Spinal disease">back</a></li>
<li><a href="/wiki/Template:Arthritis_in_children" title="Template:Arthritis in children">childhood</a></li>
<li><a href="/wiki/Template:Soft_tissue_disorders" title="Template:Soft tissue disorders">soft tissue</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_musculoskeletal_system" title="Template:Congenital malformations and deformations of musculoskeletal system">Congenital</a></li>
<li><a href="/wiki/Template:Dislocations,_sprains_and_strains" title="Template:Dislocations, sprains and strains">Injury</a></li>
<li><a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_skeletal_system_and_joints" title="Template:Eponymous medical signs for skeletal system and joints">eponymous</a></li>
<li><a href="/wiki/Template:Orthopaedic_Eponyms" title="Template:Orthopaedic Eponyms">orthopaedic</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Orthopedic_examination" title="Template:Orthopedic examination">Examination</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Bone,_cartilage,_and_joint_procedures" title="Template:Bone, cartilage, and joint procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antirheumatic_products" title="Template:Antirheumatic products">rheumatoid arthritis</a></li>
<li><a href="/wiki/Template:Antigout_preparations" title="Template:Antigout preparations">gout</a></li>
<li><a href="/wiki/Template:Topical_products_for_joint_and_muscular_pain" title="Template:Topical products for joint and muscular pain">topical analgesics</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1053
CPU time usage: 0.879 seconds
Real time usage: 1.031 seconds
Preprocessor visited node count: 4101/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 308260/2097152 bytes
Template argument size: 2331/2097152 bytes
Highest expansion depth: 12/40
Expensive parser function count: 4/500
Lua time usage: 0.316/10.000 seconds
Lua memory usage: 4.43 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  786.736      1 - -total
 40.12%  315.635      1 - Template:Reflist
 32.98%  259.497     18 - Template:Navbox
 14.45%  113.652     25 - Template:Cite_journal
 12.81%  100.785      1 - Template:Infobox_disease
 11.31%   88.962      1 - Template:Infobox
  8.80%   69.238      1 - Template:Hematological_malignancy_histology
  6.95%   54.650      7 - Template:Cite_web
  6.27%   49.358      1 - Template:Mergefrom
  5.83%   45.846      3 - Template:Fix
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:837167-0!*!0!!en!4!* and timestamp 20150711215255 and revision id 668901393
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Acute_lymphoblastic_leukemia&amp;oldid=668901393">https://en.wikipedia.org/w/index.php?title=Acute_lymphoblastic_leukemia&amp;oldid=668901393</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Acute_lymphocytic_leukemia" title="Category:Acute lymphocytic leukemia">Acute lymphocytic leukemia</a></li><li><a href="/wiki/Category:Pediatrics" title="Category:Pediatrics">Pediatrics</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_failed_verification" title="Category:All articles with failed verification">All articles with failed verification</a></li><li><a href="/wiki/Category:Articles_with_failed_verification_from_February_2013" title="Category:Articles with failed verification from February 2013">Articles with failed verification from February 2013</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_April_2014" title="Category:Articles with unsourced statements from April 2014">Articles with unsourced statements from April 2014</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_September_2012" title="Category:Articles with unsourced statements from September 2012">Articles with unsourced statements from September 2012</a></li><li><a href="/wiki/Category:Articles_to_be_merged_from_January_2015" title="Category:Articles to be merged from January 2015">Articles to be merged from January 2015</a></li><li><a href="/wiki/Category:All_articles_to_be_merged" title="Category:All articles to be merged">All articles to be merged</a></li><li><a href="/wiki/Category:Articles_with_DMOZ_links" title="Category:Articles with DMOZ links">Articles with DMOZ links</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Acute+lymphoblastic+leukemia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Acute+lymphoblastic+leukemia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Acute_lymphoblastic_leukemia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Acute_lymphoblastic_leukemia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Acute_lymphoblastic_leukemia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Acute_lymphoblastic_leukemia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Acute_lymphoblastic_leukemia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;oldid=668901393" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q180664" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Acute_lymphoblastic_leukemia&amp;id=668901393" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Acute+lymphoblastic+leukemia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Acute+lymphoblastic+leukemia&amp;oldid=668901393&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Acute_lymphoblastic_leukemia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%A7%D8%A8%D9%8A%D8%B6%D8%A7%D8%B6_%D8%A7%D9%84%D8%AF%D9%85_%D8%A7%D9%84%D9%84%D9%8A%D9%85%D9%81%D8%A7%D9%88%D9%8A_%D8%A7%D9%84%D8%AD%D8%A7%D8%AF" title="ابيضاض الدم الليمفاوي الحاد – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Leuc%C3%A8mia_limfoide_aguda" title="Leucèmia limfoide aguda – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de badge-Q17437798 badge-goodarticle" title="good article"><a href="//de.wikipedia.org/wiki/Akute_lymphatische_Leuk%C3%A4mie" title="Akute lymphatische Leukämie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Leucemia_linfoide_aguda" title="Leucemia linfoide aguda – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%84%D9%88%D8%B3%D9%85%DB%8C_%D8%AD%D8%A7%D8%AF_%D9%84%D9%86%D9%81%D9%88%D8%A6%DB%8C%D8%AF%DB%8C" title="لوسمی حاد لنفوئیدی – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Leuc%C3%A9mie_aigu%C3%AB_lymphoblastique" title="Leucémie aiguë lymphoblastique – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EA%B8%89%EC%84%B1_%EB%A6%BC%ED%94%84%EB%AA%A8%EA%B5%AC_%EB%B0%B1%ED%98%88%EB%B3%91" title="급성 림프모구 백혈병 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Akutna_limfati%C4%8Dna_leukemija" title="Akutna limfatična leukemija – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Leucemia_linfoblastica_acuta" title="Leucemia linfoblastica acuta – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%9C%D7%95%D7%A7%D7%9E%D7%99%D7%94_%D7%9C%D7%99%D7%9E%D7%A4%D7%95%D7%A6%D7%99%D7%98%D7%99%D7%AA_%D7%97%D7%A8%D7%99%D7%A4%D7%94" title="לוקמיה לימפוציטית חריפה – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/%C5%AAmin%C4%97_limfogenin%C4%97_leukemija" title="Ūminė limfogeninė leukemija – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Leukemia_limfoblastik_akut" title="Leukemia limfoblastik akut – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E6%80%A5%E6%80%A7%E3%83%AA%E3%83%B3%E3%83%91%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85" title="急性リンパ性白血病 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Akutt_lymfatisk_leukemi" title="Akutt lymfatisk leukemi – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-nn"><a href="//nn.wikipedia.org/wiki/Akutt_lymfatisk_leukemi" title="Akutt lymfatisk leukemi – Norwegian Nynorsk" lang="nn" hreflang="nn">Norsk nynorsk</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Ostra_bia%C5%82aczka_limfoblastyczna" title="Ostra białaczka limfoblastyczna – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Leucemia_linfoide_aguda" title="Leucemia linfoide aguda – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9E%D1%81%D1%82%D1%80%D1%8B%D0%B9_%D0%BB%D0%B8%D0%BC%D1%84%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B9_%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7" title="Острый лимфобластный лейкоз – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Akutna_limfoblastna_levkemija" title="Akutna limfoblastna levkemija – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%90%D0%BA%D1%83%D1%82%D0%BD%D0%B0_%D0%BB%D0%B8%D0%BC%D1%84%D0%BE%D1%86%D0%B8%D1%82%D0%BD%D0%B0_%D0%BB%D0%B5%D1%83%D0%BA%D0%B5%D0%BC%D0%B8%D1%98%D0%B0" title="Акутна лимфоцитна леукемија – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Akutna_limfati%C4%8Dna_leukemija" title="Akutna limfatična leukemija – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Akuutti_lymfaattinen_leukemia" title="Akuutti lymfaattinen leukemia – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Akut_lymfatisk_leukemi" title="Akut lymfatisk leukemi – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-te"><a href="//te.wikipedia.org/wiki/%E0%B0%85%E0%B0%95%E0%B1%8D%E0%B0%AF%E0%B1%82%E0%B0%9F%E0%B1%8D_%E0%B0%B2%E0%B0%BF%E0%B0%82%E0%B0%AB%E0%B1%8B%E0%B0%AC%E0%B1%8D%E0%B0%B2%E0%B0%BE%E0%B0%B8%E0%B1%8D%E0%B0%9F%E0%B0%BF%E0%B0%95%E0%B1%8D_%E0%B0%B2%E0%B1%81%E0%B0%95%E0%B1%87%E0%B0%AE%E0%B0%BF%E0%B0%AF%E0%B0%BE" title="అక్యూట్ లింఫోబ్లాస్టిక్ లుకేమియా – Telugu" lang="te" hreflang="te">తెలుగు</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%A1%E0%B8%B0%E0%B9%80%E0%B8%A3%E0%B9%87%E0%B8%87%E0%B9%80%E0%B8%A1%E0%B9%87%E0%B8%94%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B8%82%E0%B8%B2%E0%B8%A7%E0%B9%80%E0%B8%89%E0%B8%B5%E0%B8%A2%E0%B8%9A%E0%B8%9E%E0%B8%A5%E0%B8%B1%E0%B8%99%E0%B8%8A%E0%B8%99%E0%B8%B4%E0%B8%94%E0%B8%A5%E0%B8%B4%E0%B8%A1%E0%B9%82%E0%B8%9F%E0%B8%9A%E0%B8%A5%E0%B8%B2%E0%B8%AA%E0%B8%95%E0%B8%B4%E0%B8%81" title="มะเร็งเม็ดเลือดขาวเฉียบพลันชนิดลิมโฟบลาสติก – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%93%D0%BE%D1%81%D1%82%D1%80%D0%B8%D0%B9_%D0%BB%D1%96%D0%BC%D1%84%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BD%D0%B8%D0%B9_%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7" title="Гострий лімфобластний лейкоз – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-ur"><a href="//ur.wikipedia.org/wiki/%D8%B3%DB%8C%D8%A7%D9%84%D9%88%DB%8C%DB%81_%D8%A7%D8%B1%D9%88%D9%85%DB%8C_%D8%A7%D8%A8%DB%8C%D8%B6%D8%A7%D8%B6_%D8%AD%D8%A7%D8%AF%DB%8C" title="سیالویہ ارومی ابیضاض حادی – Urdu" lang="ur" hreflang="ur">اردو</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E6%80%A5%E6%80%A7%E6%B7%8B%E5%B7%B4%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85" title="急性淋巴性白血病 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q180664#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 27 June 2015, at 13:16.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Acute_lymphoblastic_leukemia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":118,"wgHostname":"mw1175"});
}</script>
	</body>
</html>
